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Global epidemic of overweight and obesity 
Since the end of the 1940s, obesity and its association with health and disease have become of 
growing research interest [1,2]. It was assumed that overweight and obesity will increasingly 
be present in medical practice, as people were getting older. At the population level, fat mass 
(FM) increased by facilitated access to high caloric food and increasing inactivity [3]. 
In the last four decades the prevalence of overweight and obesity have almost tripled [4,5]. In 
the year 2016 the worldwide prevalence of overweight and obesity were 39 % and 13 % 
respectively [5]. In Germany, the prevalence of overweight (men: 67.1 %, women: 53.0 %) and 
obesity (men: 23.3 %, women: 23.9 %) are considerably higher [6]. In children and adolescents, 
the increase in obesity from 1975 to 2016 has been dramatically greater than in adulthood [7]. 
Overweight and obesity are based on body mass index (BMI). Its use is recommended by the 
World Health Organization (WHO) for the definition of nutritional status in children, 
adolescents and adults [5]. 
 
Nutritional status defined by body mass index and waist circumference 
The ratio of weight (kg) divided by height (m) squared was invented by Adolphe Quetelet in 
the year 1832. Termed as the BMI, Ancel Keys demonstrated that BMI was a good indirect 
measure to assess body fatness [8]. Thus, up today, BMI is used to assess nutritional status in 
children, adolescents and adults [9]. Although or even because of the definition of overweight 
and obesity is based on BMI only, differences become evident in children, adolescents and 
adults. In adults, overweight and obesity are defined as BMI higher or equal 25 kg/m² and 30 
kg/m², respectively [9]. These BMI cut-offs are associated with increased morbidity and 
mortality [10–13]. By contrast, statistically calculated age- and sex specific BMI percentiles 
are used in children and adolescents [14]. Accordingly, overweight and obesity are defined as 
BMI > 90th and 97th percentile, respectively. These BMI percentiles had only been statistically 
extrapolated to BMI cut-offs for mortality risk in adults [15,16]. Besides, waist circumference 
(WC) is used to assess abdominal obesity [9,17,18].  
Cut-offs of BMI and WC are commonly accepted and applied in clinical and research practice. 
However, in a forty year follow-up study, Twig et al. (2016) demonstrated that, unlike BMI of 
18.3 kg/m², a BMI within the normal range in adolescence was significantly associated with 
elevated cardiovascular mortality in adulthood [19]. Furthermore, lower mortality rate was 
observed in overweight compared with normal weight adults [20]. Taking this into account, the 
definition of overweight and obesity in children, adolescents and adults has substantial 
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shortcomings.  Since, the definition is BMI-based only and BMI cut-offs were not comparably 
associated with health outcomes in all age groups, commonly accepted definition of overweight 
and obesity and its cut-offs have to be re-considered and should be related to metabolic disorders 
in children, adolescents and adults. 
 
Limitations of body mass index and waist circumference 
In epidemiological studies, overweight and obesity increase cardiometabolic risks such as 
elevated blood pressure, dyslipidemia, insulin resistance and diabetes mellitus type 2 [21–24]. 
These results are based on BMI and WC. However, using BMI and WC to evaluate overweight 
and obesity have additional limitations. On the one hand, BMI cannot differentiate between the 
two chemical body determined compartments (FM and fat-free mass, FFM). Both 
compartments increase with body weight. On the other hand, the association between BMI and 
FM differs between normal- and overweight subjects showing strongest associations in obese 
group [25]. To go beyond BMI, data of a cross-sectional study on 304 adults of the German 
Reference Centre for Body Composition in Kiel revealed, that FM in itself did not improve 
BMI in disease risk predicting [26]. Nevertheless, BMI does not give any information about 
body fat distribution, which is characterized by WC [25,27,28]. However, WC does not allow 
to differentiate between abdominal subcutaneous adipose tissue (SAT) and visceral adipose 
tissue (VAT) [29]. 
 
Beyond anthropometric traits 
To go beyond BMI, WC and FM, detailed body composition and appropriate modeling take 
into account body function and metabolic risks [25]. Computed tomography (CT) and magnetic 
resonance imaging (MRI) are the gold-standard methods to determine total adipose tissue 
(TAT), SATarms, SATtrunk, SATlegs and VAT. Unlike CT, MRI is the most suitable measurement 
in children and adolescents because it does not expose them to radiation. 
Cardiometabolic risks have been mainly related to VAT and liver fat in obese adolescents and 
adults [30–34]. In a cross-sectional as well as longitudinal analysis SATtrunk and VAT were 
positively associated with cardiometabolic risks in women, whereas SATlegs was inversely 
related to insulin resistance and triglycerides [35]. Other studies in children, adolescents and 
adults have found positive associations between insulin resistance, inflammation and either 
VAT or liver fat [36–38]. However, the associations between regional fat depots and 
cardiometabolic risks have only been investigated in selected age groups. Comparing different 
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age groups, it is imperative to analyze these associations systematically by using identical 
methods and outcomes in normal- and overweight children, adolescents and adults. 
  
Methods to determine body composition 
In clinical and research practice, different methods are used to assess nutritional status and body 
composition. Table I1 gives an overview about established measurement techniques. 
Nutritional status and central adiposity can be indirectly assessed by anthropometric parameters 
(e.g. BMI and WC). Measuring BMI and WC are inexpensive and fast to perform in all age 
groups. However, as mentioned above, no differentiation between either FM and FFM or SAT 
and VAT can be undertaken. Further, based on a two-compartment model, which divides the 
body into fat and fat-free compartments [39], FM and FFM can be indirectly determined by 
bioelectrical impedance analysis (BIA) and air displacement plethysmography (ADP). 
Although these methods are fast and applicable in children, adolescents and adults, 
determination of FM and FFM relies on algorithms and have a reduced accuracy in lean and 
obese subjects as well as under disease conditions. On the molecular level, dilution techniques 
(D2O and NaBr) are used to assess total and extracellular water, respectively. Besides, bone 
mineral content can be measured by dual X-ray absorptiometry (DXA). Dilution techniques 
and DXA require an expensive equipment. Further, in Germany, DXA application is ethically 
not allowed in children and adolescents due to radiation exposure. Nevertheless, these methods 
have a high outcome precision. Combining ADP, dilution techniques and DXA results in a four-
compartment (4C) model, with which FM and FFM can be calculated by minimizing 
shortcomings of individual methods [39]. On a tissue level, TAT, regional SAT and VAT can 
be directly measured by CT or MRI. These are gold-standard methods in determining adipose 
tissues. However, an expensive equipment is required, which is often in high demand in clinical 
setting. Although anthropometric traits cannot differentiate between FM and FFM and, 
additionally, other methods of body composition, having a higher precision of FM or TAT are 
available, BMI is still recommended for the definition of overweight an obesity [5].  
Analyzing the associations between either anthropometric traits or body composition and 
cardiometabolic risks in children, adolescents and adults, we used different body composition 
methods to investigate their value systematically. Taking this into account, FM determined by 
4C model and TAT as assessed by MRI are interchangeably used for metabolic risk assessment. 
However, on the molecular level, FM is one chemical body component. By contrast, on the 
tissue level, TAT consists of different chemical body components [40]. Therefore, the 
interchangeable use of FM and TAT should be considered critically. 
   
 Table I1. Methods used in clinical and research practice to assess nutritional status and body composition1  
 Method Outcomes Advantages Shortcomings  
 BMI nutritional status 
quick; inexpensive equipment; convenient for all 
age groups; minimal training required 
no differentiation between FM and FFM; affected by ethnicity; less 
sensitive in thin children 
 
 WC central adiposity 
quick; inexpensive equipment; minimal training 
required 
no differentiation between SAT and VAT  
 Skinfolds SAT quick; inexpensive equipment 
references based on norms during 1970s; considerable expertise and 
training necessary; does not describe lean body mass 
 
 BIA resistance, reactance, phase angle 
quick; inexpensive equipment; portable; 
applicable in children and adolescents  
population specific; poor accuracy in individuals and groups; relies 
on prediction equations; inaccuracy in leaner and obese children 
 
 HD body volume and density gold standard in density measurement 
expensive equipment; difficult to perform in children; estimation of 
respiratory volume results in largest variability  
 
 ADP body volume and density 
quick; relatively high accuracy; minimal training 
required; applicable in children and adolescents 
expensive equipment; relies on algorithms; reduced accuracy in 
disease states 
 
 DXA 
lean body mass, FM, bone mass and 
bone mineral density 
minimal training required; differentiation of bone 
and soft tissue; high precision; low radiation 
exposure 
expensive equipment; relies on algorithms; bias due to body size, 
sex, fatness; in Germany exclusion of children due to ethical reason  
 
 D2O, NaBr TBW, ECW and ICW easy to administer isotopes expensive equipment; needs labor for analyses  
 MRI 
AT, SAT, VAT, MM, OM, ectopic 
fat in liver, skeletal muscle, pancreas 
high accuracy and reproducibility for whole-body 
and regional adipose tissue and skeletal muscle; 
no radiation 
expensive equipment; high level of training and expertise needed; 
equipment often in high demand in clinical settings; requires 
children to remain still for extended periods 
 
 CT 
AT, SAT, VAT, MM, OM, ectopic 
fat in liver, skeletal muscle, pancreas 
high accuracy and reproducibility for whole-body 
and regional adipose tissue and skeletal muscle 
expensive equipment; radiation exposure; radiation safety training 
required; equipment often in high demand in clinical settings   
 
 QMR FM, lean tissue, free and total water quick; minimal training required expensive equipment; few systems available worldwide  
 Ultrasound SAT, MM thickness, OM, liver fat 
moderately expensive equipment; less time 
consuming than MRI and CT 
preperitoneal fat used as an approximation of VAT; high level of 
training and expertise needed; no universal guidelines for 
measurement of adipose tissue 
 
 
Abbreviations: BMI, body mass index; FM, fat mass; FFM, fat-free mass; WC, waist circumference; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; BIA, bioelectrical 
impedance analysis; HD, hydrodensitometry; ADP, air displacement plethysmography; DXA, dual X-ray absorptiometry; TBW, total body water; ECW, extracellular water; ICW, intracellular 
water; MRI, magnetic resonance imaging; AT, adipose tissue; MM, muscle mass; OM, organ mass; CT, computed tomography; QMR, quantitative magnetic resonance. 
1Referring to the tables from Müller et al. 2016, Horan et al. 2015 and Lee and Gallagher 2008 [39,41,42]. 
Methods colored in green were used within this doctoral thesis.   
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Differentiation between fat mass and adipose tissue  
FM consists of fat content in adipose tissue, organs, skeletal muscle, hands, feet and head 
(Figure I1). The overall density for total FM is assumed to be 0.90 kg/l [43]. Instead, fat in 
adipose tissue, water content, protein content and mineral content are included in TAT [43–45]. 
Regarding this, TAT contents have different densities. Thus, overall density for TAT (0.92 kg/l) 
is different from FM [46]. 
  
 
Figure I1. Relationship between total adipose tissue and total fat mass.1 
1Referring to the figure from Al-Gindan et al. [40]. 
*Siri [43], ‡Fidanza et al. [44], §Brozek et al. [45], †Garrow [46] 
Abbreviations: UWW, underwater weighing; D2O, deuterium oxide; MRI, magnetic resonance 
imaging; CT, computed tomography. 
 
Based on data obtained by adipose tissue biopsy, fat in adipose tissue is lower in lean subjects 
than in obese subjects (Figure I1) [40]. Overall, fat content in adipose tissue is assumed to be 
80 %. However, as mentioned in the Report of the task group on reference man fat fraction per 
adipose tissue shows a wide variation between 62 % and 91 % [47–50]. Therefore, we 
questioned the idea to interchangeably use FM and TAT in relation to metabolic risk 
assessment.  
So far, fat fraction per adipose tissue was determined by adipose tissue biopsy, which was 
undertaken during bariatric surgery. Nevertheless, implementing adipose tissue biopsy in 
healthy subjects is not allowed for ethical reason. Instead, we used a new approach based on in 
vivo body composition data on FM and TAT to determine fat fraction per adipose tissue. 
Up today, the associations between either anthropometric traits or detailed body composition 
on cardiometabolic risks have not been systematically investigated and compared in different 
age groups. Moreover, it is questionable to define overweight and obesity based on BMI only. 
Established cut-offs are not comparably associated with metabolic disorders in children, 
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adolescents and adults. It is further doubtful to interchangeably use FM and TAT for metabolic 
risk assessment. 
 
Objectives 
Based on this background, overweight and obesity have an impact on public health, clinical 
medicine and research. Therefore, the present thesis analyzed  
 
(i) the associations between regional fat depots and cardiometabolic risks in normal- 
and overweight children, adolescents and adults, 
(ii) new cut-offs of BMI and WC based on body composition and insulin resistance, 
(iii) fat fraction per adipose tissue and their association with metabolic risks. 
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Abstract 
 
Objectives 
To determine age-related associations between fat mass (FM), regional fat depots and 
cardiometabolic traits in normal- and overweight children, adolescents and adults. 
 
Methods 
Detailed body composition (regional subcutaneous and visceral adipose tissue; SAT, VAT) by 
whole-body magnetic resonance imaging (MRI), FM and fat-free mass by air-displacement 
plethysmography, systolic and diastolic blood pressure (SBP, DBP), triglycerides (TG), high-
density lipoprotein cholesterol (HDL), plasma glucose and plasma insulin were measured in 
433 subjects (BMI: 23.6 (21.0–27.7); 151 children and adolescents, aged 6–18 years, 150 young 
adults, aged 18–30 years and 132 adults, aged 30–60 years). Data were derived from pooled 
data of the ‘Reference Center for Body Composition’ in Kiel, Germany. Insulin resistance was 
determined by the homeostatic model assessment of insulin resistance (HOMA-IR). Partial 
correlations and multivariate linear regression analyses were used to evaluate the associations 
between body composition and cardiometabolic traits. A descriptive approach was used to 
demonstrate age-dependent differences in associations between body fat depots and insulin 
resistance, independent of BMI. 
 
Results 
FM, SAT, and VAT increased from childhood to adulthood with low VAT in children and 
adolescents. When compared to children, TG was higher in adults. HDL and DBP did not differ 
between age groups. Insulin resistance was highest in male adolescents and female young 
adults. Associations between body fat depots and cardiometabolic traits were seen after puberty 
with no associations in pre- and intrapubertal children. When compared to FM, SAT and VAT 
had the strongest association with insulin resistance in adults. This association was independent 
of BMI. 
 
Conclusions 
Associations between individual body fat depots and most cardiometabolic traits became 
evident after puberty only. The strongest associations were observed between insulin resistance 
and abdominal fat in adults. The impact of VAT was independent of BMI.
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Introduction 
To address the impact of overweight on cardiometabolic risk most studies are based on body 
mass index (BMI).1–3  However, BMI can neither differentiate between fat mass (FM) and fat-
free mass (FFM) nor give detailed information about body fat distribution.4,5 To go beyond 
BMI, detailed body composition and appropriate modeling taking into account body function 
have to be considered.6 Magnetic resonance imaging (MRI) and computed tomography are the 
gold-standard methods to determine trunk and peripheral subcutaneous adipose tissue (SAT) 
and visceral adipose tissue (VAT). In children and adolescents, MRI is the most suitable 
measurement because it does not expose them to radiation. 
Our present knowledge about the association between individual body fat depots and cardio-
metabolic risk factors is mainly based on studies on adults. In addition, there is only limited 
knowledge about regional fat depots in children and adolescents. In a cross-sectional study SAT 
and VAT were lower in children compared to adults.7 In a longitudinal study, SAT increased 
during adolescence, whereas VAT remained low.8 By contrast, both, SAT and VAT, increased 
between age of 11 to 13 years.9 With regard to gender differences, girls compared with boys 
had greater masses of VAT and SAT.10 This was contrary to other authors who observed that 
VAT was greater in boys than in girls.11 
In obese adolescents and adults cardiometabolic traits and insulin resistance have been mainly 
related to VAT and liver fat.12–16 In children and adolescents the degree of insulin resistance 
rises from pre- to intrapuberty and decreases after puberty.17,18 However, the association 
between cardiometabolic traits and insulin resistance with detailed body composition has not 
been well characterized in children and adolescents. As in adults, SAT and VAT were 
differently associated with cardiometabolic traits in children and adolescents.19–22 Both, SAT 
and VAT were independently correlated with blood pressure,19 whereas VAT was positively 
associated with plasma triglycerides (TG) and negatively associated with high-density 
lipoprotein cholesterol (HDL).20 In addition, there was a positive relationship between either 
VAT or SAT and insulin resistance.20–23 
Untill now, there is no systematic study of the associations between individual body fat depots 
and cardiometabolic risk in different age groups. The aim of this study was to determine the 
associations between MRI-derived individual fat depots and cardiometabolic traits in children 
and adolescents compared to young and older adults. Furthermore, we investigated the 
associations between insulin resistance, relative to BMI, and regional fat depots.
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Methods 
All studies had been approved by the Ethical Committee of Christian-Albrechts-University of 
Kiel, Germany, and conducted according to the guidelines laid down in the “Declaration of 
Helsinki”. Written informed consent was obtained from each subject and, in state of minority, 
from its legal guardian before participation. 
 
Subjects 
This investigation was a secondary analysis of data collected at the “Reference Center for Body 
Composition” (Institute of Human Nutrition and Food Science at the University of Kiel, 
Germany) between 2005 and 2016. In this cross sectional study, data of 433 healthy Caucasian 
subjects (151 children and adolescents, aged 6-18 years, 150 young adults, aged 18-30 years 
and 132 adults, aged 30-60 years) were analyzed. Exclusion criteria were metallic implants, 
smoking, pregnancy, chronic or acute diseases, and medication intake that influences body 
composition. Subjects were recruited by notice boards postings and advertisements in the local 
newspaper. Study measurements of anthropometry, body composition, detailed body 
composition by whole body MRI and cardiometabolic variables were performed in children, 
adolescents and adults. Self-assessment of pubertal stage was determined according to the 
definition of Marshall and Tanner.24 Based on breast and genital stages pubertal status was 
categorized into three groups (prepubertal: Tanner I; intrapubertal: Tanner II-III, postpubertal: 
Tanner ≥ IV).18 In this analysis prepubertal and intrapubertal subjects were grouped together. 
This was done because they did not differ in associations between body composition and 
cardiometabolic traits (data not shown) and because of a low number of prepubertal children (n 
= 26). 
 
Anthropometric measures 
Body weight was measured to the nearest 0.01 kg using an electronic Tanita scale coupled to 
the BOD POD® Body Composition Tracking System (Life Measurement Instruments, Concord, 
California, USA). Body height was assessed to the nearest 0.5 cm by using a stadiometer 
(SECA, Modell 220, Hamburg, Germany). BMI was calculated as body weight (kg) / body 
height (m)². To define overweight and obesity for children and adolescents (>90th percentile; 
>97th percentile) German age- and sex-specific references were used.25 Waist circumference 
(WC) was measured midway between the lowest rib and the top of the iliac crest with the 
subjects standing in upright position. The measurement was made with a nonelastic plastic tape 
placed parallel to the floor at the end of a normal expiration. 
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Densitometry 
Air-displacement plethysmography (ADP) was perfomed by BOD POD® device to assess body 
composition. Child-specific equations were used to determine FM as in detail described 
elsewhere.26 In adults, FM was calculated using the equation by Siri et al.27 FFM was then 
calculated from the difference between body weight and FM. Because of reported difficulties 
in BOD POD calibration in one of the children studies cross-validated gender specific equations 
of FM were developed for children and adolescents as procedure is described elsewhere.28 222 
children and adolescents were randomly split into two parts. 155 (91 female, 64 male) were 
assigned to the generation group, with 67 (31 female, 36 male) subjects in the cross-validation 
group. When compared to generation group, the cross-validation group did not differ in age, 
gender, pubertal status, height, weight, BMI, WC and FM measured by bio-impedance analysis. 
The correlation coefficients between FM measured by bio-impedance analysis and predicted 
FM based on BOD POD algorithm did not differ between the two groups. Following equations 
based on stepwise multiple regression analysis were developed for children and adolescents: 
FMfemale (%) = 1.808 * BMI - 7.7 * 10
5 * age4 - 0.531 * body weight (kg) + 53.672 * height (m) 
+ 0.416 * FMADP(%) + 0.139 * WC (cm) - 86.307. 
FMmale (%) = 0.961 * BMI + 7.0 * 10
5 * age4 + 0.336 * FMADP (%) - 2.853. 
Based on calculated FM and FFM, FM-Index (FMI) and FFM-Index (FFMI) were calculated 
for children and adolescents as FM (kg) / height (m)n and FFM (kg) / height (m)n. Height-
independent FM is confounded by age in adolescents, whereas age was not included as a 
significant independent variable in children. By contrast, height-independent FFM is 
confounded by age in children but not in adolescents. Age-adjusted power of height (n) was 
determined using log – log regression analysis29 (FMI: n = 6.1, 2.3 and FFMI: n = 2.3, 2.9, 
respectively for children and adolescents). In adults FMI and FFMI were calculated as FM (kg) 
/ height (m)2 and FFM (kg) / height (m)2. 
 
Magnetic resonance imaging (MRI) 
As described previously, detailed body composition of all subjects was performed by using 
whole-body MRI with a 1.5T scanner (Magnetom Vision or Magnetom Avanto, Siemens 
Medical Systems, Erlangen, Germany).30,31 Briefly, participants were examined in a supine 
position with their arms extended above their heads and they were asked to hold their breath 
during measurement of abdominal and thoracic regions for image acquisition. In the present 
analysis volumes of SAT and VAT were manually segmented by using segmentation software 
(SliceOmatic 4.3 and 5.0, Tomovision, Montreal, Canada). SAT was analyzed from ankle to 
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wrist. In this case SATlegs were defined from ankle to femoral heads and SATarms were defined 
from humerus heads to wrist. Between femoral and humerus heads volume of SATtrunk was 
assessed. VAT was defined as intra-abdominal fat between femoral heads and the top of the 
liver. Volumes of SAT and VAT were determined by the sum of all adipose tissue areas (cm²) 
multiplied by slice thickness. Volume data were then transformed into tissue masses by using 
the following density: 0.923 g/cm3 for SAT and VAT. 
 
Cardiometabolic risk factors 
Systolic and diastolic blood pressure were measured by manual sphygmomanometer in a seated 
position. After an 8-h overnight fast blood samples were taken and analyzed by standard 
procedures. HDL was assessed enzymatically by Konelab-20i-Analyzer (Konelab, Espoo, 
Finland). Triglyceride and plasma glucose were analyzed enzymatically using a Konelab-Test-
Kit (Thermo Clinical Labsystems, Frankfurt, Germany). Plasma insulin was measured by 
radioimmunoassay (Adaltis, Freiburg, Germany). Insulin resistance was then calculated by 
homeostasis model assessment of insulin resistance (HOMA-IR):  
HOMA-IR = plasma glucose (mmol/L) x plasma insulin (µU/ml) / 22.5 (ref.32) 
 
Statistical analysis 
Statistical analyses were performed with SPSS statistical software (SPSS 24.0, Inc., Chicago, 
Illinois, USA). All data are given as median and interquartil range (IQR) because of not 
normally distributed data. Kruskal-wallis test with bonferroni correction was performed for 
more than two groups (pre- and intrapubertal subjects, postpubertal subjects, young adults and 
adults). To examine the association of individual body components on cardiometabolic traits, 
age- and gender-adjusted partial correlations were performed. Differences in correlation 
coefficients between age groups were tested by using the method of Eid, Gollwitzer, Schmitt33. 
Further, stepwise multivariate linear regression analyses were done. Four models were 
conducted. Model 1 included FMI, Model 2 SATtrunk, Model 3 VAT and Model 4 SATtrunk and 
VAT as independent variables. All models were adjusted for age and gender. In addition, a 
descriptive approach was used to demonstrate age-dependent differences in individual body 
components between three different HOMA-IR per BMI groups (low, normal and high). These 
three groups were stratified according to their age dependent deviation from the regression line. 
Cut-offs were chosen from tertiles between HOMA-IR and BMI (low: residuals < -0.48, < -
0.90, < -0.92, < -0.69; normal: residuals ≤ 0.16 and ≥ -0.48, ≤ 0.25 and ≥ -0.90, ≤ 0.00 and ≥ -
0.92, ≤ 0.29 and ≥ -0.69; high: residuals > 0.16, > 0.25, > 0.00, > 0.29, respectively for children, 
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adolescents, young adults and adults). All tests were two-sided and level of significance was 
set at P < 0.05. 
 
Results 
Detailed body composition: differences between age groups 
The characteristics of the study population are shown in Table 1. When compared with 
children, height, weight, FM and FFM were significantly higher in adolescents and with no 
significant differences to adults. When compared with young adults, VAT was lower in children 
and adolescents. In males, VAT was significantly higher in older compared with young adults. 
In females, SATtotal, SATarms and SATtrunk were higher in young adults compared with children 
and adolescents. By contrast, SATtrunk was the only subcutaneous fat depot in males which was 
significantly higher in young adults compared to children and adolescents. 
 
Cardiometabolic risks: differences between age groups 
In females, plasma insulin and HOMA-IR were highest in young adults when compared to other 
age groups (Table 1). In males, plasma insulin and HOMA-IR were highest in adolescents. In 
both genders, HOMA-IR did not differ between adolescents and adults. There were no 
differences in SBP, DBP and HDL between the different age groups, except for SBP in male 
adolescents, and high TG level in female young adults and male adults.  
 
Associations between body composition and cardiometabolic traits: differences between age 
groups 
Age- and gender-adjusted partial correlation coefficients between individual body fat depots 
and cardiometabolic traits are shown in Table 2. In general, correlation coefficients were low 
to moderate. As for SBP, DBP, TG and plasma glucose, significant associations were seen after 
puberty only. The associations between SATtrunk and either SBP or DBP or TG did not differ in 
adolescents, young adults and adults. Strongest associations were observed between plasma 
insulin levels or HOMA-IR and truncal fat depots (SATtrunk, VAT). When compared with 
adults, the associations between individual body fat depots and HDL were higher in children 
and adolescents. 
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 Table 1. Characteristics of the study population stratified by age group and gender  
 age groups# (1) Children (2) Adolescents (3) Young Adults (4) Adults  
  Females Males Females Males Females Males Females Males  
 n 37 43 41 30 69 81 69 63  
 Age (y) 10.9 (9.4 – 13.4) 12.3 (9.4 – 14.1) 15.8 (15.3 – 16.3) 16.3 (15.6 – 17.3) 26.0 (24.0 – 26.0)1,2 25.0 (23.0 – 27.0)1,2 44.0 (36.0 – 50.0)1,2,3 41.0 (35.0 – 50.0)1,2,3  
 Height (m) 1.49 (1.34 – 1.61) 1.58 (1.42 – 1.70) 1.68 (1.65 – 1.72)1 1.78 (1.73 – 1.83)1 1.70 (1.65 – 1.75)1 1.81 (1.76 – 1.87)1 1.67 (1.63 – 1.72)1 1.79 (1.76 – 1.84)1  
 Weight (kg) 43.4 (29.4 – 56.9) 53.1 (32.3 – 72.5) 65.6 (55.0 – 80.7)1 73.0 (64.0 – 101.6)1 69.5 (61.0 – 87.2)1 78.6 (71.1 – 85.1)1 68.0 (61.4 – 79.6)1 81.2 (73.5 – 92.3)1  
 OW (OB) (%) 35.1 (27.0) 34.9 (16.3) 43.9 (36.6) 43.3 (36.7) 37.7 (29.0) 33.3 (8.6) 40.6 (18.8) 46.0 (17.5)  
 BMI (kg/m²) 19.3 (16.5 – 25.5) 19.0 (15.7 – 24.8) 21.8 (19.8 – 29.6) 23.4 (20.0 – 31.1)1 23.9 (21.7 – 31.7)1 23.4 (22.1 – 25.7)1 24.3 (21.7 – 27.7)1 24.5 (23.2 – 28.7)1  
 FM (kg) 9.4 (4.7 – 19.9) 9.9 (5.0 – 19.4) 16.8 (12.4 – 31.9)1 14.0 (9.3 – 29.6)1 22.1 (17.4 – 37.8)1 13.2 (10.1 – 18.9) 23.4 (16.7 – 30.5)1 17.2 (12.9 – 24.4)1  
 FFM (kg) 32.5 (24.5 – 39.3) 40.6 (27.4 – 50.0) 47.6 (41.6 – 51.1)1 57.7 (54.8 – 68.2)1 47.5 (43.6 – 52.0)1 64.5 (59.0 – 68.7)1 45.0 (41.8 – 50.2)1 65.3 (59.4 – 69.3)1  
 FMI (kg/mn) 0.95 (0.55 – 1.56) 0.70 (0.48 – 0.98) 4.8 (3.9 – 10.2) 4.0 (2.6 – 8.2) 7.8 (6.0 – 14.2) 3.8 (3.0 – 5.8) 8.3 (6.3 – 10.9) 5.3 (3.9 – 7.3)  
 FFMI (kg/mn) 13.0 (12.1 – 14.5) 12.9 (11.8 – 15.1) 10.1 (9.3 – 11.4) 11.1 (10.5 – 12.0) 16.4 (15.5 – 17.9) 19.6 (18.5 – 20.5) 16.0 (15.0 – 17.8) 19.9 (18.7 – 21.5)  
 Adipose tissue (kg) 9.5 (7.1 – 19.3) 9.0 (4.7 – 18.5) 15.0 (11.9 – 29.1) 11.6 (8.4 – 25.0) 21.5 (17.5 – 34.6)1 12.9 (10.8 – 18.6)1 22.6 (17.0 – 30.8)1 18.2 (14.0 – 24.5)1,3  
   SAT total (kg) 9.1 (6.9 – 18.8) 8.7 (4.6 – 17.9) 14.5 (11.5 – 27.9) 11.3 (8.1 – 23.2) 20.0 (17.0 – 33.3)1 11.8 (10.2 – 17.2) 21.4 (16.1 – 28.3)1 14.8 (11.7 – 18.6)1  
      SAT arms (kg) 1.2 (1.0 – 2.2) 1.2 (0.7 – 2.1) 1.7 (1.4 – 3.2) 1.4 (1.1 – 3.0) 2.2 (1.8 – 3.6)1 1.5 (1.4 – 2.2) 2.3 (1.7 – 3.0)1 1.9 (1.6 – 2.2)1  
      SAT trunk (kg) 2.9 (2.1 – 6.3) 2.6 (1.3 – 6.7) 4.7 (3.7 – 13.5) 3.8 (2.8 – 10.4) 8.6 (6.2 – 14.3)1 4.7 (3.7 – 8.1)1 9.1 (6.3 – 13.3)1 6.8 (4.9 – 9.0)1  
      SAT legs (kg) 5.3 (3.8 – 8.7) 4.6 (2.6 – 8.4) 8.0 (6.4 – 12.5)1 6.0 (4.4 – 11.0) 9.8 (8.2 – 13.9)1 5.6 (4.8 – 7.3) 8.9 (7.0 – 11.9)1 6.3 (5.3 – 7.7)1  
   VAT (kg) 0.36 (0.22 – 0.87) 0.29 (0.16 – 0.88) 0.47 (0.34 – 0.96) 0.64 (0.37 – 1.30) 1.11 (0.60 – 1.71)1,2 1.13 (0.70 – 2.15)1 1.36 (0.68 – 2.29)1,2 2.50 (1.69 – 5.17)1,2,3  
 SBP (mmHg) 120 (108 – 121) 120 (110 – 125) 118 (110 – 120) 128 (120 – 134)1 115 (110 – 125) 120 (110 – 125)2 118 (110 – 125) 120 (115 – 130)  
 DBP (mmHg) 70 (70 – 80) 75 (70 – 80) 75 (70 – 80) 76 (70 – 85) 80 (70 – 82) 80 (75 – 85) 80 (70 – 80) 80 (75 – 85)  
 TG (mg/dl) 75 (59 – 96) 67 (47 – 121) 85 (70 – 104) 86 (69 – 114) 102 (73 – 145)1 91 (70 – 127)1 86 (70 – 108) 106 (78 – 143)1  
 HDL (mg/dl) 54 (46 – 60) 53 (46 – 62) 52 (43 – 66) 51 (42 – 59) 55 (46 – 72) 51 (40 – 57) 65 (48 – 73) 46 (33 – 58)  
 Glucose (mg/dl) 89 (84 – 94) 90 (85 – 96) 87 (82 – 93) 91 (86 – 94) 88 (83 – 92) 86 (78 – 94) 94 (86 – 99)2,3 99 (94 – 105)1,2,3  
 Insulin (µU/ml) 8.7 (4.9 – 11.1) 7.7 (4.4 – 11.6) 12.1 (6.9 – 15.3) 10.7 (6.9 – 14.5) 12.5 (8.0 – 18.6)1 7.8 (6.3 – 10.1) 9.2 (6.8 – 12.3)3 7.7 (5.9 – 14.1)  
 HOMA-IR 1.92 (0.98 – 2.36) 1.84 (0.92 – 2.79) 2.49 (1.46 – 3.11) 2.34 (1.46 – 3.08) 2.68 (1.62 – 4.34)1 1.64 (1.20 – 2.15) 2.20 (1.53 – 2.84) 1.98 (1.40 – 3.31)  
 Abbreviations: OW, overweight; OB, obese; FM, fat mass; FFM, fat-free mass; FMI, fat mass index; FFMI, fat-free mass index; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDL, high-density lipoprotein cholesterol. 
Data are given as median and IQR. 
#(1), pre- and intrapubertal children; (2), postpubertal adolescents; (3), young adults (18-30 years old); (4), adults (30-60 years old). 
npower of height which is unequal in pre-and intrapubertal, postpubertal and adult stage (FMI: 6.1, 2.3, 2.0, 2.0; FFMI: 2.3, 2.9, 2.0, 2.0, respectively). 
1significantly different from gender-dependent pre- and intrapubertal subjects; 2significantly different from gender-dependent postpubertal subjects; 3significantly different from gender-dependent 
young adults (Kruskal-wallis test with bonferroni correction, P < 0.05). 
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 Table 2. Age- and gender-adjusted partial correlations between parameters of body composition and cardiometabolic traits in children, adolescents and adults  
  Correlation coefficient (r)  
  FMI  SATarms   SATtrunk  SATlegs   VAT  
 age groups# 1 2 3 4  1 2 3 4  1 2 3 4  1 2 3 4  1 2 3 4  
 n 80 71 150 132  80 71 150 132  80 71 150 132  80 71 150 132  80 71 150 132  
 SBP 0.17b,c 0.31 0.43 0.42  0.29 0.27 0.39 0.27  0.25 0.31 0.43 0.42  0.29 0.28 0.36 0.30  0.19c 0.27c 0.27c 0.48  
 DBP 0.14a,b,c 0.42 0.41 0.37  0.33 0.43 0.35 0.25  0.29 0.42 0.38 0.40  0.30 0.37 0.34 0.23  0.24c 0.42 0.26c 0.45  
 TG 0.00a,b,c 0.37 0.35 0.24  -0.05a,b 0.34 0.31 0.16  0.02a,b 0.34 0.37 0.24  -0.12a,b,c 0.29 0.26 0.12  0.16a,c 0.54 0.36 0.41  
 HDL -0.53b,c -0.42 -0.27 -0.31  -0.50b,c -0.39 -0.26 -0.24  -0.52b -0.41 -0.28 -0.33  -0.52b,c -0.33 -0.21 -0.22  -0.50b,c -0.37 -0.29 -0.30  
 Glucose -0.15c -0.23b,c 0.07c 0.30  -0.17b,c -0.25b,c 0.15 0.30  -0.24b,c -0.27b,c 0.18 0.30  -0.19b,c -0.22b,c 0.05c 0.33  -0.26b,c -0.17b,c 0.35 0.37  
 Insulin 0.55 0.54 0.48 0.48  0.55 0.52 0.52 0.39  0.57 0.55 0.56 0.53  0.53 0.55c 0.37 0.34  0.64 0.55 0.53 0.50  
 HOMA-IR 0.51 0.51 0.45 0.51  0.52 0.48 0.50 0.41  0.52 0.51 0.54 0.55  0.50 0.52 0.34 0.37  0.59 0.52 0.53 0.55  
Abbreviations: FMI, fat mass index; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; 
HDL, high-density lipoprotein cholesterol. 
#1, pre- and intrapubertal children; 2, postpubertal adolescents; 3, young adults (18-30 years old); 4, adults (30-60 years old). 
significant correlation coefficients in bold, P < 0.05 
asignificantly different from correlation coefficient in postpubertal adolescents, bsignificantly different from correlation coefficient in young adults, csignificantly different from 
correlation coefficient in adults, P < 0.05 [method of Eid, Gollwitzer, Schmitt36] 
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Using stepwise multivariate linear regression analysis, the explained variance and respective 
beta coefficients of cardiometabolic traits as dependent variables and FMI, SATtrunk, VAT and 
the combination of SATtrunk and VAT as independent variables are shown in Table 3. The 
explained variance of cardiometabolic traits was moderate, maximally, 35.2% of the variance 
of HOMA-IR was explained by SATtrunk and VAT in adults. 
When compared with adolescents and adults, the explained variances of SBP, DBP, TG and 
plasma glucose by body fat depots were low (≤ 5.3%) in children. However, the explained 
variances of HOMA-IR and plasma insulin by parameters of body composition differed only 
slightly between children, adolescents and adults. The explained variance of HDL by body fat 
depots decreased from children to adults. 
When compared to FMI, the explained variance of plasma insulin and HOMA-IR by SATtrunk 
and VAT were moderately increased in young and older adults. When compared to FMI, 
SATtrunk and VAT did not exceed the explained variance of HDL, whereas abdominal fat depots 
added to the variance of TG in adolescents. 
 
Association between detailed body composition and insulin resistance 
Investigating subjects with low HOMA-IR (insulin sensitive), normal HOMA-IR or high 
HOMA-IR (insulin resistance) relative to their BMI, age-dependent differences in individual 
body components between these groups became evident (Table 4). In children and adolescents, 
no differences were found in body fat depots between groups differing in insulin resistance. By 
contrast, in young adults, adipose tissue, SATtotal, SATtrunk and SATlegs were significantly higher 
in insulin resistant subjects. In older adults, VAT was highest in insulin resistant subjects.
  
 Table 3. Multivariate linear regression on cardiometabolic traits as dependent variables  
 independent 
variables FMI
a 
 
SATtrunka 
 
VATa 
 
SATtrunk + VATa 
 
 age groups# 1 2 3 4  1 2 3 4  1 2 3 4  1 2 3 4  
  R² β R² β R² β R² β  R² β R² β R² β R² β  R² β R² β R² β R² β  R² βb R² βb R² βb R² βb  
 n 80 71 150 132  80 71 150 132  80 71 150 132  80 71 150 132  
 SBP 0.0 0.18 5.9 0.27 17.9 0.50 15.0 0.44  3.5 0.26 6.3 0.27 17.7 0.47 15.5 0.41  0.0 0.20 4.6 0.24 6.5 0.28 20.6 0.53  3.5 0.02 6.3 0.02 17.7 -0.06 19.4 0.52  
 DBP 0.0 0.16 15.7 0.42 16.1 0.47 12.4 0.40  5.3 0.31 16.7 0.42 13.6 0.41 14.8 0.41  4.2 0.26 16.1 0.41 6.3 0.27 19.0 0.51  5.3 0.09 16.7 0.20 13.6 0.00 18.4 0.50  
 TG 0.0 0.00 11.7 0.36 11.3 0.40 4.5 0.25  0.0 0.02 9.9 0.33 12.6 0.40 4.6 0.24  0.0 0.17 27.2 0.53 11.8 0.37 15.2 0.46  0.0 0.17 32.6 0.96 12.6 0.20 15.8 0.47  
 HDL 25.4 -0.54 15.1 -0.41 5.6 -0.29 6.8 -0.30  23.2 -0.60 14.7 -0.40 6.3 -0.29 7.6 -0.30  21.6 -0.54 12.2 -0.37 6.6 -0.28 6.7 -0.31  23.2 -0.25 14.7 -0.09 6.6 -0.28 7.6 -0.17  
 Glucose 0.0 -0.14 0.0 -0.23 0.0 0.08 7.1 0.31  3.7 -0.27 5.8 -0.27 2.7 0.20 7.1 0.29  4.8 -0.28 0.0 -0.17 11.5 0.36 11.0 0.39  4.8 -0.28 5.8 0.24 11.5 0.36 11.3 0.40  
 Insulin 19.4 0.47 27.4 0.54 18.5 0.51 22.8 0.54  20.7 0.56 29.1 0.55 25.6 0.57 27.9 0.55  26.4 0.59 29.3 0.55 22.3 0.49 24.8 0.58  26.4 0.59 29.3 0.55 28.2 0.24 31.0 0.31  
 HOMA-IR 16.3 0.43 24.4 0.50 16.3 0.48 25.6 0.57  16.8 0.51 24.9 0.50 24.4 0.55 30.0 0.57  21.2 0.53 26.7 0.52 23.3 0.50 29.8 0.63  21.2 0.53 26.7 0.52 27.9 0.28 35.2 0.64  
Abbreviations: FMI, fat mass index; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride;  
HDL, high-density lipoprotein cholesterol.  
#1, pre- and intrapubertal children; 2, postpubertal adolescents; 3, young adults (18-30 years old); 4, adults (30-60 years old). 
amodel with independent variable/variables in bold adjusted for age and gender 
R², additional explained variance (%) by independent variable/variables which is/are in bold compared to the base model which includes age and gender 
bβ-coefficient of VAT. 
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Table 4. Differences in body fat depots between three groups (low HOMA-IR per BMI, normal HOMA-IR per BMI and high HOMA-
IR per BMI) stratified by age group 
 
  HOMA-IR/BMI ↓ HOMA-IR/BMI = HOMA-IR/BMI ↑ p-value  
 (1) Children      
 n 26 27 26   
 FM (kg) 14.8 (4.7 – 23.4) 7.1 (4.2 – 12.8) 10.7 (7.6 – 20.5) 0.038  
 FFM (kg) 36.7 (27.4 – 49.8) 28.4 (23.6 – 38.9) 42.1 (32.4 – 47.1) 0.011  
 Adipose tissue (kg) 11.9 (4.7 – 22.9) 8.3 (4.7 – 12.6) 9.8 (8.5 – 22.5) 0.111  
   SAT total (kg) 11.5 (4.5 – 22.1) 7.9 (4.5 – 12.0) 9.4 (8.3 – 21.9) 0.121  
     SAT arms (kg) 1.5 (0.7 – 2.5) 1.1 (0.7 – 1.7) 1.3 (1.0 – 2.3) 0.193  
     SAT trunk (kg) 3.9 (1.3 – 9.3) 2.6 (1.3 – 3.9) 3.1 (2.4 – 8.0) 0.132  
     SAT legs (kg) 6.1 (2.6 – 10.5) 4.5 (2.5 – 6.4) 5.1 (4.5 – 9.4) 0.102  
   VAT (kg) 0.53 (0.18 – 0.97) 0.29 (0.16 – 0.47) 0.36 (0.26 – 1.02) 0.171  
 HOMA-IR 0.84 (0.57 – 2.05) 1.60 (0.97 – 1.91) 2.74 (2.07 – 4.10) < 0.001  
 (2) Adolescents      
 n 23 24 23   
 FM (kg) 24.2 (12.5 – 35.5) 15.5 (9.9 – 29.6) 13.5 (10.8 – 31.9) 0.174  
 FFM (kg) 56.9 (49.3 – 64.9) 50.4 (44.4 – 57.3) 49.3 (43.9 – 52.1) 0.058  
 Adipose tissue (kg) 22.4 (11.9 – 31.3) 12.0 (9.7 – 24.6) 13.3 (11.1 – 30.2) 0.222  
   SAT total (kg) 21.1 (11.6 – 30.1) 11.6 (9.3 – 23.2) 12.9 (10.6 – 24.4) 0.222  
     SAT arms (kg) 2.6 (1.3 – 3.8) 1.4 (1.2 – 2.8) 1.5 (1.3 – 3.1) 0.338  
     SAT trunk (kg) 8.1 (3.6 – 13.5) 3.8 (3.2 – 9.7) 4.5 (3.1 – 13.9) 0.190  
     SAT legs (kg) 10.0 (6.2 – 13.7) 6.9 (4.7 – 11.3) 6.8 (5.8 – 12.5) 0.265  
   VAT (kg) 0.72 (0.44 – 1.20) 0.43 (0.31 – 0.81) 0.51 (0.32 – 1.20) 0.306  
 HOMA-IR 1.62 (0.97 – 2.49) 2.02 (1.38 – 2.89) 3.25 (2.72 – 5.49) < 0.001  
 (3) Young Adults      
 n 47 47 47   
 FM (kg) 17.6 (12.3 – 37.8) 15.6 (10.3 – 19.7) 20.8 (14.8 – 26.1) 0.034  
 FFM (kg) 62.1 (49.4 – 68.7) 58.7 (50.3 – 65.4) 53.6 (44.3 – 63.1) 0.010  
 Adipose tissue (kg) 16.5 (11.1 – 34.6) 16.0 (11.0 – 19.6) 20.4 (14.8 – 26.1) 0.013  
  SAT total (kg) 15.2 (10.4 – 33.3) 14.4 (10.3 – 19.3) 18.9 (14.2 – 25.0) 0.008  
    SAT arms (kg) 1.9 (1.4 – 3.1) 1.7 (1.4 – 2.2) 2.2 (1.6 – 2.8) 0.066  
    SAT trunk (kg) 5.9 (3.8 – 14.6) 5.8 (3.8 – 8.1) 8.8 (6.2 – 12.0) 0.006  
    SAT legs (kg) 8.1 (5.2 – 13.9) 6.4 (5.0 – 8.9) 8.7 (6.2 – 10.3) 0.021  
  VAT (kg) 0.96 (0.53 – 2.29) 1.25 (0.76 – 1.85) 1.1 (0.89 – 2.60) 0.411  
 HOMA-IR 1.21 (0.84 – 1.95) 1.68 (1.49 – 2.04) 4.00 (2.78 – 5.55) < 0.001  
 (4) Adults      
 n 44 44 44   
 FM (kg) 20.9 (14.6 – 27.5) 19.5 (15.5 – 24.6) 22.5 (15.1 – 30.6) 0.519  
 FFM (kg) 58.2 (46.4 – 68.4) 51.3 (43.0 – 59.8) 53.1 (44.2 – 64.4) 0.051  
 Adipose tissue (kg) 18.9 (15.7 – 29.3) 18:3 (14.6 – 24.6) 21.7 (16.0 – 31.4) 0.277  
  SAT total (kg) 16.9 (13.8 – 24.8) 17.3 (13.7 – 22.1) 18.6 (14.9 – 27.6) 0.433  
    SAT arms (kg) 2.1 (1.7 – 2.8) 2.0 (1.6 – 2.4) 2.2 (1.7 – 2.8) 0.339  
    SAT trunk (kg) 7.7 (5.9 – 11.0) 7.1 (5.2 – 9.9) 8.4 (5.5 – 13.1) 0.380  
    SAT legs (kg) 6.9 (5.7 – 10.4) 7.3 (6.3 – 10.1) 8.3 (6.5 – 10.8) 0.643  
  VAT (kg) 2.07 (1.32 – 3.59) 1.57 (0.75 – 2.39) 2.39 (1.23 – 4.90) 0.013  
 HOMA-IR 1.39 (1.06 – 1.66) 1.84 (1.63 – 2.28) 3.75 (2.67 – 4.88) < 0.001  
 
Abbreviations: FM, fat mass; FFM, fat-free mass; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.  
(1), pre- and intrapubertal children; (2), postpubertal adolescents; (3), young adults (18-30 years old); (4), adults (30-60 years old).  
Group 1: HOMA-IR/BMI ↓, residuals (1) < -0.48, (2) < -0.90, (3) < -0.92, (4) < -0.69; Group 2: HOMA-IR/BMI =, residuals (1) ≤ 
0.16 and ≥ -0.48, (2) ≤ 0.25 and ≥ -0.90, (3) ≤ 0.00 and ≥ -0.92, (4) ≤ 0.29 and ≥ -0.69; Group 3: HOMA-IR/BMI ↑, residuals (1) > 
0.16, (2) > 0.25, (3) > 0.00, (4) > 0.29. 
significant correlation coefficients in bold (Kruskal-wallis test with bonferroni correction, P < 0.05) 
 
Chapter II Fat depots and cardio-metabolic traits 
33 
 
Discussion 
Up to now, there are limited data on the association between regional fat depots and metabolic 
disturbance in normal- and overweight children and adolescents compared with adults.34,35 To 
our knowledge, the present study is first to systematically investigate detailed body composition 
by age group and gender as well as its associations to cardiometabolic traits in 6 to 60 year old 
subjects. 
 
Detailed body composition in different age groups 
In both genders, VAT was low in children and adolescents compared with adults (Table 1). 
This is in line with previous data.7,8 However, other authors reported that during childhood, 
growth of VAT decelerated with increasing age.34 In our study sexual dimorphism was apparent 
after puberty only with males having more VAT than females. By contrast, other authors 
observed higher masses of VAT in girls compared to boys.10 
 
Cardiometabolic risks in different age groups  
As shown in Table 1, in males, insulin resistance increased from pre- and intrapuberty to 
postpuberty, with changes to young adulthood in females only. These findings support previous 
data.36,37 By contrast, other authors reported that the increase in insulin resistance from 
childhood to adulthood was independent of gender.38 Studies on blood pressure showed that 
SBP and DBP increased with age.38,39 These results are contrary to our findings. 
 
Associations between body composition and cardiometabolic traits in different age groups 
Low and moderate associations were observed between cardiometabolic traits and body fat 
depots in normal- and overweight children, adolescents and adults (Table 2). This is in line with 
previous data.38 However, moderate associations were seen after puberty only. These findings 
indicate that in pre- and intrapubertal children individual body components are not related to 
cardiometabolic risk as it is in older subjects. Accordingly, a study on pre- and intrapubertal 
children found no associations between abdominal fat depots vs. blood pressure and blood lipids 
in European Americans.40 Positive associations became evident between SATtrunk, VAT and 
cardiometabolic traits in adolescents.19 
Overall, there was a limited explained variance of cardiometabolic traits by FMI and different 
regional fat depots (Table 3). When compared to FMI, abdominal fat depots, especially VAT, 
were stronger associated to insulin resistance in adults than in children and adolescents. The 
associations between HDL and body fat depots decreased with age. As HDL is positively 
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associated to physical activity in children, adolescents and adults,41,42 a possible explanation 
may be increasing sedentary behavior with age which is due to school entry and entering the 
workplace.43,44 This is in line with the finding that children improved HDL by increased 
physical activity which was independent of weight change.45 
 
Associations between detailed body composition and insulin resistance 
To address the role of individual body fat depots on insulin resistance, independent of BMI, 
differences in age groups became evident (Table 4). In children and adolescents, there were no 
differences in body fat depots between groups differing in insulin resistance. By contrast, 
regional SAT depots were significantly different in young adults, with VAT as associated to 
insulin resistance in older adults only. Our findings suggest that VAT becomes an important 
determinant of insulin resistance as age increased to adulthood. In our study, VAT was very 
low in children and adolescents and started to increase in young adults (Table 1). This is in line 
with other data that VAT is a primary determinant of insulin resistance in adults only.46–48 
 
Study Strengths and Limitations 
To our knowledge, this is the first study to systematically investigate age-related associations 
between individual body components and cardiometabolic traits in children and adolescents 
compared to adults. Detailed body composition was measured by MRI. This is the gold-
standard method of body composition. We have used two different approaches. First, an 
analytic approach was chosen to examine age-dependent associations between cardiometabolic 
traits and body fat depots. Secondly, a descriptive approach was conducted to investigate age-
dependent differences in body fat depots in groups differing in insulin resistance. A limitation 
of this study is that we have used cross-sectional data only. Thus, no causal relationships can 
be derived from our data. 
 
Conclusion 
Associations between regional fat depots and cardiometabolic traits were seen after puberty 
only. The impact of FMI on cardiometabolic traits is limited. With regard to HOMA-IR, this 
was improved by measuring individual fat depots in adults. The strongest associations were 
observed between abdominal fat depots and insulin resistance. When compared with adults, 
VAT was low in normal- and overweight children and adolescents. VAT has no association 
with insulin resistance groups in children, adolescents and young adults. The role of VAT is 
apparent in adults only. 
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Abstract 
 
Objective 
This study aims to determine associations between anthropometric traits, regional fat depots 
and insulin resistance in children, adolescents and adults to define new cut-offs of body mass 
index (BMI) or waist circumference (WC). 
 
Design 
Cross-sectional data were assessed in 433 children, adolescents and adults [aged: 6-60 years, 
BMI: 23.6 (21.0-27.7) kg/m²]. Total adipose tissue (TAT), regional subcutaneous adipose tissue 
(SATtotal, SATtrunk) and visceral adipose tissue (VAT) were determined by whole-body 
magnetic resonance imaging, fat mass (FM) by air displacement plethysmography. Insulin 
resistance was evaluated by homeostasis model assessment of insulin resistance (HOMA-IR). 
Bivariate as well as partial correlations and regression analyses were used. Cut-off values of 
BMI and WC related to regional fat depots and HOMA-IR were analysed by receiver operating 
characteristics curve. 
 
Results 
In adults, TAT, SATtotal and SATtrunk increased linearly with increasing BMI and WC, whereas 
they followed a cubic function in children and adolescents with a steep increase at BMI and 
WC ≥ 1 standard deviation score, and VAT at WC ≥ 2 standard deviation score. Sex differences 
were apparent in adults with women having higher masses of TAT and SAT and men having 
higher VAT. Using established BMI or WC cut-offs, correspondent masses of TAT, SATtotal, 
SATtrunk and VAT increased from childhood to adulthood. In all age groups, there were positive 
associations between BMI, WC, SATtrunk, VAT and HOMA-IR. When compared with 
normative cut-offs of BMI or WC, HOMA-IR-derived cut-offs of regional fat depots were 
lower in all age groups. 
 
Conclusions 
Associations between BMI, WC and regional fat depots varied between children, adolescents, 
young and older adults. When compared with BMI-derived and WC-derived values, an insulin 
resistance-derived cut-off corresponded to lower masses of regional fat depots. Thus, 
established BMI and WC cut-offs are not appropriate to assess metabolic disturbances 
associated with obesity; therefore, new cut-offs of BMI and WC are needed for clinical practice. 
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Introduction 
Body mass index (BMI) and waist circumference (WC) are used to assess obesity and 
abdominal obesity in children, adolescents and adults (1,2). In epidemiological studies these 
anthropometric traits are positively associated with cardiometabolic traits (3–6). However, 
anthropometric traits have considerable limitations. BMI can neither differentiate between fat 
mass (FM) and fat-free mass (FFM) nor between regional fat depots (7–9). In addition, WC 
does not allow to distinguish between abdominal subcutaneous adipose tissue (SAT) and 
visceral adipose tissue (VAT) (10). In daily practice, health related cut-offs of BMI and WC 
are established in adult population (2). In children and adolescents BMI and WC ≥ 97 age-
specific and sex-specific percentiles are used as cut-offs (11,12). The cut-off data had been 
extrapolated to mortality risk in overweight and obese adults at BMI of 25 and 30 kg/m² (13,14). 
These references are widely used in clinical and research practice. However, the associations 
between anthropometric traits and regional fat depots as well as insulin resistance have not been 
systematically addressed and may vary between children and adolescents compared with adults. 
Therefore, we questioned the statistical approach based on mortality risk estimates obtained in 
epidemiological studies. 
 
To go beyond simple anthropometric traits, detailed body composition as assessed by whole-
body magnetic resonance imaging (MRI) or computed tomography is used (9). The aims of this 
study were to determine associations between simple anthropometric traits and regional fat 
depots in children, adolescents and adults and to compare masses of regional fat depots at either 
BMI or WC or insulin resistance-derived cut-offs in different age and sex-groups. 
 
Methods 
Subjects 
This investigation was a secondary analysis. The study sample included pooled data of 433 
healthy Caucasian subjects who participated in different studies at the “Reference Center for 
Body Composition” (Institute of Human Nutrition and Food Science at the University of Kiel, 
Germany) between 2005 and 2016 as described in detail elsewhere (15–18). Cross-sectional 
data of 151 children and adolescents [aged: 6-18 years; BMI: 21.0 (18.0-27.6)], 150 young 
adults [aged: 18-30 years; BMI: 23.5 (22.0-26.7)] and 132 adults [aged: 30-60 years; BMI: 24.4 
(22.8-28.5)] were analyzed. The recruitment was conducted by local advertisements and notice 
board postings. Exclusion criteria were metallic implants, pregnancy, smoking, chronic or acute 
diseases and medication intake. Each participant underwent examinations of anthropometry and 
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body composition at the Institute of Human Nutrition (University of Kiel, Germany). Whole-
body MRI was performed at the Clinic for Diagnostic Radiology (University Medical Center 
Schleswig-Holstein, Kiel, Germany). Pubertal stage was self assessed according to the 
definition of Marshall and Tanner (19). Breast and genital stages were used to categorize 
pubertal status into three groups (prepubertal: Tanner I; intrapubertal: Tanner II-III, 
postpubertal: Tanner ≥ IV) (20). Because of a low number of prepubertal children (n = 26), 
prepubertal and intrapubertal subjects were grouped together. Before participation, written 
informed consent was received from each participant and, in state of minority, from its legal 
guardian. All studies were authorized by the ethical committee of the University Kiel and 
conducted according to the guidelines laid down in the “Declaration of Helsinki”. 
 
Anthropometric measurements 
Body weight was determined to the nearest 0.01 kg using a Tanita scale coupled to the BOD 
POD® Body Composition Tracking System (Life Measurement Instruments, Concord, 
California, USA) with subjects wearing underwear. Height was assessed without shoes to the 
nearest 0.5 cm by using a stadiometer (SECA, Modell 220, Hamburg, Germany). BMI was 
calculated as body weight (kg) / body height (m)². WC was measured with the subjects standing 
in upright position midway between the lowest rib and the top of the iliac crest. At the end of a 
normal expiration the measurement was done with a nonelastic plastic tape positioned parallel 
to the floor. BMI- and WC-values were converted to standard deviation score (SDS) values in 
children and adolescents using the LMS method from Cole (21). The calculation was based on 
German reference data for children and adolescents (11,12). Cut-offs for the definition of 
obesity and abdominal obesity in children and adolescents were BMI ≥ 2 SDS and WC ≥ 2 SDS 
(22). In adults, obesity was defined as BMI ≥ 30 kg/m², whereas cut-offs for abdominal obesity 
were WC > 88 cm in women and WC > 102 cm in men (23).  
 
Densitometry 
Air displacement plethysmography was perfomed by BOD POD® device. In children and 
adolescents, specific equations were used to assess fat mass (FM) as in detail described 
elsewhere (24). The equation by Siri et al. was used to calculate FM in adults (25). 
 
Magnetic resonance imaging 
Detailed body composition was performed by using whole-body MRI with a 1.5T scanner 
(Magnetom Vision or Magnetom Avanto, Siemens Medical Systems, Erlangen, Germany) as 
Chapter III Regional fat depots at different cut-offs 
55 
 
in detail described elsewhere (26,27). Briefly, participants were examined in a supine position 
with their arms extended above their heads. SATarms were defined from wrist to humerus heads. 
SATlegs were defined from femoral heads to ankle. Between humerus and femoral heads volume 
of SATtrunk was assessed. VAT was defined from the top of the liver to femoral heads. In the 
present analysis volumes of SAT and VAT were manually segmented by using segmentation 
software (SliceOmatic 4.3 and 5.0, Tomovision, Montreal, Canada). Tissue volumes were 
determined from the sum of all areas (cm²) multiplied by slice thickness. Masses of regional 
SAT and VAT were calculated as tissue volumes multiplied by density (0.923 g/cm3). 
 
Homeostasis model assessment of insulin resistance 
Blood samples were taken after an 8-h overnight fast and analyzed by standard procedures. 
Plasma glucose was determined enzymatically using Konelab-Test-Kit (Thermo Clinical 
Labsystems, Frankfurt, Germany). Plasma insulin was measured by radioimmunoassay 
(Adaltis, Freiburg, Germany). Homeostasis model assessment of insulin resistance (HOMA-
IR) was used to determine insulin resistance:  
HOMA-IR = plasma glucose (mmol/L) x plasma insulin (µU/ml) / 22.5 (28). Because there is 
no recommended threshold for insulin resistance in children, adolescents and adults, a cut-off 
of 2.5 was used to separate participants into having normal or elevated HOMA-IR (29,30). 
 
Statistical analysis 
All statistical analyses were carried out with SPSS statistical software (SPSS 24.0, Inc., 
Chicago, Illinois, USA). Data were given as median and interquartil range because of not 
normally distributed data. Mann-Whitney U test and Kruskal-wallis test with bonferroni 
correction were used to assess differences between groups. To examine the association between 
BMI and FM bivariate correlations were performed. Age- and gender adjusted partial 
correlations were used to determine the association between anthropometric traits, regional fat 
depots and insulin resistance in children, adolescents and adults. Further, regression analyses 
were done to determine the associations between BMI, WC and regional fat depots in different 
age groups. Receiver operating characteristics (ROC) curve analyses demonstrated the ability 
of regional fat depots to discriminate against elevated HOMA-IR. Further, Youden’s index was 
used to obtain the optimal cut-off value for the detection of elevated HOMA-IR. Significance 
was set at P < 0.05 for all tests. 
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Results 
The main characteristics of the study population are shown in Table 1. In both genders, BMI, 
WC, total adipose tissue (TAT), SATtrunk and VAT were significantly higher in young adults 
when compared with children. When compared to male young adults, WC, FM, TAT and VAT 
were higher in male adults with no differences in females. In females, HOMA-IR was highest 
in young adults, whereas in males, HOMA-IR was highest in adolescents. In children, 
anthropometric traits and regional fat depots did not differ between males and females. By 
contrast, WC, FM, TAT, SATtotal, SATtrunk and VAT differed significantly between female and 
male adults. 
 
Association between body mass index and fat mass in children, adolescents and adults 
Associations between BMI and FM in children, adolescents, young adults and adults are shown 
in Figure 1. These associations were strong in children and adolescents but moderate in young 
and older adults. The explained variance of FM by BMI was highest in children and decreased 
with increasing age. Sex differences in the BMI - FM - association became apparent in 
adolescents and were most obvious in adults. Sensitivity of BMI to predict FM was high in all 
age groups; by contrast, specificity decreased from children to adults. 
 Table 1. Characteristics of the study population stratified by age group and  gender1  
 
 
Children Adolescents Young adults Adults  
 female male female male female male female male  
 BMI (kg/m²) 19.3
2 
(16.5 – 25.5) 
19.0 
(15.7 – 24.9) 
21.8 
(19.8 – 29.6) 
23.43 
(20.0 – 31.1) 
23.93 
(21.7 – 31.8) 
23.43 
(22.1 – 25.7) 
24.33 
(21.7 – 27.7) 
24.53 
(23.2 – 28.7) 
 
 WC (cm) 65.5 
(57.5 – 83.8) 
73.0 
(58.0 – 87.5) 
75.33 
(68.8 – 99.5) 
78.3 
(72.5 – 99.0) 
81.03 
(74.0 – 96.8) 
85.03 
(81.0 – 89.0) 
83.03 
(77.5 – 94.0) 
89.53,4,5 
(84.0 – 99.0) 
 
 FM (%) 22.6 
(16.1 – 36.3) 
20.1 
(15.5 – 27.1) 
25.9 
(23.0 – 39.5) 
20.2 
(14.6 – 31.2) 
32.03 
(27.9 – 43.4) 
16.5 
(13.2 – 22.9) 
34.33 
(28.4 – 41.6) 
22.15 
(16.5 – 27.9) 
 
 TAT (kg) 9.5 
(7.1 – 19.3) 
9.0 
(4.7 – 18.5) 
15.0 
(11.9 – 29.1) 
11.6 
(8.4 – 25.0) 
21.53 
(17.5 – 34.6) 
12.93 
(10.8 – 18.6) 
22.63 
(17.0 – 30.8) 
18.23,5 
(14.0 – 24.5) 
 
 SATtotal (kg) 
9.1 
(6.9 – 18.8) 
8.7 
(4.6 – 17.9) 
14.5 
(11.5 – 27.9) 
11.3 
(8.1 – 23.2) 
20.03 
(17.0 – 33.3) 
11.8 
(10.2 – 17.2) 
21.43 
(16.1 – 28.3) 
14.83 
(11.7 – 18.6) 
 
 SATtrunk (kg) 
2.9 
(2.1 – 6.3) 
2.6 
(1.3 – 6.7) 
4.7 
(3.7 – 13.5) 
3.8 
(2.8 – 10.4) 
8.63 
(6.2 – 14.3) 
4.73 
(3.7 – 8.1) 
9.13 
(6.3 – 13.3) 
6.83 
(4.9 – 9.0) 
 
 VAT (kg) 0.36 
(0.22 – 0.87) 
0.29 
(0.16 – 0.88) 
0.47 
(0.34 – 0.96) 
0.64 
(0.37 – 1.30 
1.13,4 
(0.6 – 1.7) 
1.13 
(0.7 – 2.1) 
1.43,4 
(0.7 – 2.3) 
2.53,4,5 
(1.7 – 5.2) 
 
 HOMA-IR 1.9 
(1.0 – 2.4) 
1.8 
(0.9 – 2.8) 
2.5 
(1.5 – 3.1) 
2.3 
(1.5 – 3.1) 
2.73 
(1.6 – 4.3) 
1.6 
(1.2 – 2.1) 
2.2 
(1.5 – 2.8) 
2.0 
(1.4 – 3.3) 
 
 
1BMI, body mass index; FM, fat mass; HOMA-IR, homeostasis model assessment of insulin resistance; SAT, 
subcutaneous adipose tissue; TAT, total adipose tissue; VAT, visceral adipose tissue; WC, waist circumference. 
2Median (IQR) (all such values). 
Median in bold, significantly different from female (Mann-Whitney U test, P < 0.05). 
3significantly different from children for either females or males; 4significantly different from adolescents for either 
females or males; 5significantly different from young adults for either females or males (Kruskal-wallis test with 
bonferroni correction, P < 0.05). 
 
  
   
   
Figure 1. Association between body mass index (BMI) and fat mass (%) in children, adolescents, young adults and adults stratified by gender. Cut-offs of BMI and BMI standard 
deviation score (SDS) are presented as vertical dashed lines (11, 12). Range of normal fat mass (%) is presented as horizontal dashed (females) and solid (males) lines (35, 36). 
Abbreviation: FM, fat mass. 
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Association between anthropometric traits and masses of regional fat depots 
Associations between BMI, WC and regional fat depots in children, adolescents, young adults 
and adults are shown in Figure 2. In children and adolescents, associations between either BMI 
or WC and regional fat depots followed a cubic function. TAT, SATtotal and SATtrunk were 
constant until about 1.0 SDS and started to increase beyond that number. VAT increased with 
WC > 2 SDS. In contrast to children and adolescents, the associations between either BMI or 
WC and regional fat depots were linear in young and older adults. TAT, SATtotal, SATtrunk and 
VAT increased with increasing BMI or WC. Sex differences became apparent in adolescents 
and were most obvious in adults with females having higher masses of TAT, SATtotal and 
SATtrunk and males having higher masses of VAT. 
The explained variance of all regional fat depots by BMI-SDS and WC-SDS was high in 
children and adolescents. It decreased in young and older adults. When compared to males in 
young and older adults, the explained variance of TAT, SATtotal and SATtrunk by BMI and WC 
was higher in females.  
The cut-offs of 2 SDS in BMI and WC were appropriate to discriminate higher masses of 
regional fat depots in children and adolescents. In adults, WC cut-offs were less appropriate to 
discriminate higher masses of regional fat depots. 
 
TAT, SATtotal, SATtrunk and VAT at either elevated BMI or WC differed between age and sex 
groups (Table 2). The corresponding regional fat depots increased from childhood to adulthood. 
Further, in adolescents and adults, masses of TAT, SATtotal and SATtrunk were higher in females 
with males having higher masses of VAT.  
 
Association between anthropometric traits and masses of regional fat depots with homeostasis 
model assessment of insulin resistance 
Associations between either anthropometric traits or regional fat depots and HOMA-IR in 
children, adolescents, young adults and adults are shown in Figure 3. In all age groups moderate 
and positive associations were found between either BMI or WC or SATtrunk or VAT and insulin 
resistance. Accordingly, sex differences were minor. When compared with anthropometric 
traits and SATtrunk, highest correlations were seen between VAT and insulin resistance with no 
differences between the different age groups. 
  
Children Adolescents Young adults Adults 
    
    
    
    
Figure 2. Association between anthropometric traits and regional fat depots in children, adolescents, young adults and adults stratified by gender. Cut-offs of body mass index standard deviation 
score (BMI-SDS), BMI, waist circumference (WC)-SDS and WC are presented as vertical dashed lines. Cut-offs based on receiver operating characteristics (ROC) curve analyses (Table 2) for 
predicting elevated HOMA-IR (>2.5) are presented as horizontal solid lines. Accordingly, dashed/dotted (total children), dashed (females) and solid (males) arrows marked the corresponding 
BMI-SDS, BMI, WC-SDS or WC values. Abbreviations: SAT, subcutaneous adipose tissue; TAT, total adipose tissue; VAT, visceral adipose tissue. 
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 Table 2. Cut-offs of regional fat depots on elevated HOMA, BMI and WC in children, adolescents, young adults and adults1  
  Children2 Adolescents2 Young adults2 Adults2  
  HOMA-IR  BMI or WC HOMA-IR BMI or WC HOMA-IR BMI or WC HOMA-IR BMI or WC  
 TAT (kg) 9.8 23.3/23.13 12.9 23.9/27.9 19.0 26.4/33.4 20.3 27.0/32.9  
 SAT total (kg) 12.8 22.3/22.2 21.6 22.7/27.1 17.7 23.4/31.8 18.4 21.4/30.3  
 SAT trunk (kg) 3.6 5.7/6.1 8.5 7.7/6.7 6.7 10.8/12.0 10.5 10.0/10.9  
 VAT (kg) 0.5 0.8/0.6 0.5 1.2/0.3 1.9 3.2/1.4 2.1 5.1/1.9  
 
1BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; SAT, subcutaneous adipose tissue; SDS, standard deviation score; TAT, 
total adipose tissue; VAT, visceral adipose tissue; WC, waist circumference. 
2Masses of regional fat depots based on elevated HOMA-IR, BMI (in children and adolescents BMI-SDS) or WC (in children and adolescents WC-SDS). 
3Male regional fat mass/female regional fat mass (all such values). 
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Figure 3. Association between anthropometric traits, regional fat depots and homeostasis model assessment of insulin resistance (HOMA-IR) in children, adolescents, young adults and adults 
stratified by gender. Cut-off of elevated HOMA-IR (>2.5), which is used in receiver operating characteristics curve analyses, is presented as horizontal dashed lines. All correlations were 
significant at P < 0.05. Abbreviations: SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; WC, waist circumference. 
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Using a HOMA-IR of 2.5 as a cut-off, the corresponding masses of regional fat depots varied 
between the different age groups (Table 2) Comparing the corresponding masses of TAT, 
SATtotal, SATtrunk and VAT derived from either normative anthropometric traits or HOMA-IR, 
cut-offs showed lower masses for the latter calculation. These cut-offs are demonstrated as 
horizontal lines in Figure 2. Each gender-dependent vertical arrow marked the corresponding 
BMI or WC value. An insulin resistance derived classification led to lower BMI or WC cut-
offs for elevated disease risk. 
 
Discussion 
In adults TAT, SATtotal, SATtrunk and VAT increased linearly with increasing BMI and WC. 
When compared to adults, the associations followed a cubic function in children and 
adolescents. There was a sex-difference: Females had higher masses of TAT and SAT with 
males having higher VAT. Using established BMI or WC cut-offs, TAT, SATtotal, SATtrunk and 
VAT increased from childhood to adulthood. When compared to the normative cut-offs of BMI 
or WC, insulin resistance derived cut-offs of regional fat depots were lower in all age groups. 
To our knowledge, the current study is first to systematically investigate associations between 
BMI and WC vs. TAT, SATtotal, SATtrunk and VAT by age group and gender as well as to 
compare masses of regional fat depots at either BMI or WC or insulin resistance derived cut-
offs in a greater population of subjects aged 6 to 60 years. 
In children and adolescents FM, TAT, SAT and VAT followed a cubic function with a steep 
increase at BMI and WC ≥ 1 SDS (Figure 2). This is contrary to previous studies showing linear 
relationships between anthropometric traits and regional fat depots in adolescents (10,31,32) 
whereas VAT increased exponentially with increasing BMI Z-Score or WC (33). The latter data 
are in line with our results. However, to our knowledge the cubic association between 
anthropometric traits and either TAT or SATtotal or SATtrunk or VAT has not been previously 
shown in children and adolescents. Our results indicated that in children and adolescents, 
masses of regional fat depots started to increase beyond a BMI and WC ≥ 1 SDS only. Contrary 
to children and adolescents, in young and older adults masses of regional fat depots increased 
linearly with increasing anthropometric traits with females having higher masses of TAT, 
SATtotal and SATtrunk and males having higher masses of VAT. These data confirm with 
previous findings in adults (9,18,34,35). 
The corresponding masses of TAT, SATtotal, SATtrunk and VAT using BMI and WC cut-offs 
differed between age and sex groups and increased from childhood to adulthood (Table 2). 
These findings indicated that BMI and WC cut-offs inadequately describe masses of regional 
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fat depots in different age and sex groups. In addition, insulin resistance derived cut-offs of 
regional fat depots varied between age groups and also increased from childhood to adulthood. 
Comparing cut-offs of masses of individual fat depots derived from anthropometric traits and 
HOMA-IR gave considerably lower values for the latter calculation (Figure 2, Table 2). The 
data showed only moderate associations between measures of body fat and insulin resistance. 
Our findings suggested that insulin resistance (as reflected by biomarkers, i.e. HOMA-IR) is 
not primarily determined by masses of fat depots. In line with our results, previous cross-
sectional data also showed only moderate associations between regional fat depots and insulin 
resistance in children, adolescents and adults (10,36,37). When compared to BMI, recent 
studies have shown that FM adjusted for height improved the prediction of insulin resistance in 
adults with no improvements in children and adolescents (38–42). However, insulin resistance 
results from a multidimensional dynamic process which cannot be addressed in a cross-
sectional study. Therefore, longitudinal data from birth to adulthood would be conducive. In 
addition, other determinants of insulin resistance are important to be considered: Adipose tissue 
remodeling is altered by hyperplasia and or hypertrophy (43). Studies have shown that 
hypertrophy led to increased secretion of pro-inflammatory cytokines which were supposed to 
result in the development of insulin resistance (44–46). Accordingly, most data on hypertrophy 
and its association to insulin resistance in humans were obtained in obese subjects undergoing 
bariatric surgery (47,48). A final argument is that HOMA-IR most probably reflects hepatic 
insulin resistance (49). By contrast, the euglycemic clamp technique, which is considered as 
the present gold standard in the assessment of insulin sensitivity, measures the stimulation of 
peripheral, i.e. skeletal muscle glucose uptake (50). Based on our data we found a correlation 
of r = -0.67 between euglycemic clamp technique and HOMA-IR (51,52). Therefore, the 
association between fat mass and insulin sensitivity also depends on the methods used to assess 
insulin resistance.  
To our knowledge, this is the first study to systematically investigate associations between 
anthropometric traits and regional fat depots in children, adolescents and adults and to compare 
masses of regional fat depots at either BMI or WC or insulin resistance derived cut-offs. 
Regional fat depots were measured by whole-body MRI. This is the gold-standard method of 
body composition. In addition, metabolically derived cut-offs were chosen to compare the 
corresponding masses of regional fat depots in different age groups. A limitation of this study 
is that we have analyzed pre- and intrapubertal subjects together due to the small number of 
prepubertal children. Thus, no further differentiation can be done in this age group. In addition, 
the associations of HOMA-IR by anthropometric traits and regional fat depots were only 
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moderate. Additional data on muscle mass and ectopic lipids in muscle and liver may add to 
improve these associations.  
Associations between simple anthropometric traits and regional fat depots differed between 
children and adolescents vs. young and older adults. When compared with the established BMI 
or WC cut-offs corresponding masses of regional fat depots varied between age groups and 
gender. There were positive associations between anthropometric traits and regional fat depots 
with HOMA-IR. Insulin resistance derived cut-offs of regional fat depots were lower than the 
corresponding values based on normative BMI- and WC cut-offs. This knowledge may 
contribute to a better evaluation of nutritional status based on health outcomes instead of 
normative cut-offs. Our results indicated that using established BMI or WC cut-offs in children, 
adolescents and adults partly fails to detect subjects with an elevated risk of insulin resistance. 
Thus, there is need for new cut-offs of BMI and WC for clinical practice. Since obesity is 
defined as an excessive fat accumulation which impairs health (53). Thus, in future, BMI and 
WC should be replaced by measures of body fat and regional fat depots taking into account 
their associations with metabolic disturbances. 
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Abstract 
 
Background/Objectives: We investigated whether fat mass (FM) and total adipose tissue (TAT) 
can be used interchangeably and FM per TAT adds to metabolic risk assessment. 
 
Subjects/Methods: Cross-sectional data were assessed in 377 adults (aged 18-60 years; 51.2% 
women). FM was measured by either 4-compartment (4C) model or quantitative magnetic 
resonance (QMR); total-, subcutaneous- and visceral adipose tissue (TAT, SAT, VAT) and liver 
fat by whole-body magnetic resonance imaging (MRI); leptin, insulin, homeostasis model 
assessment of insulin resistance (HOMA-IR), C-reactive protein (CRP) and triglycerides; 
resting energy expenditure and respiratory quotient by indirect calorimetry were determined. 
Correlations and stepwise multivariate regression analyses were performed.  
 
Results: FM4C and FMQMR were associated with TAT (r4C = 0.96, rQMR = 0.99) with a mean FM 
per TAT of 0.85 and 1.01, respectively. Regardless of adiposity, there was a considerable inter-
individual variance of FM/TAT-ratio (FM4C/TAT: 0.77-0.94; FMQMR/TAT: 0.89-1.10). Both, 
FM4C and TAT were associated with metabolic risks. Further, FM4C/TAT was positively related 
to leptin but inversely to CRP. There was no association between FM4C/TAT and VAT/SAT or 
liver fat. FM4C/TAT added to the variance of leptin and CRP.  
 
Conclusions: FM4C and TAT cannot be used interchangeably. Independent of FM or TAT, 
FM4C/TAT adds to metabolic risk assessment. 
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Introduction 
The 4-compartment (4C) model, quantitative magnetic resonance (QMR) and imaging 
technologies (magnetic resonance imaging, MRI; computed tomography, CT) are gold 
standards to assess fat mass (FM) and adipose tissue volume.1,2 The 4C-model includes the 
measurement of body weight, body volume, bone mineral content and body water to assess 
lipid content of the body, whereas the volume of adipose tissue (either total adipose tissue 
(TAT) or regional, i.e. visceral and subcutaneous adipose tissue, VAT, SAT) is most accurately 
quantified by MRI.1 When compared with the 4C-model (which uses an equation to calculate 
FM) FM can be directly and precisely assessed with QMR.2 Up to now, the results of the 
different methods have been used interchangeably. The association between FM and TAT and 
its possible association with metabolic risk has not been addressed in clinical studies. 
Based on data obtained by adipose tissue biopsy, FM is assumed to be about 80% of TAT with 
variations between 62% and 91%.3–6 While differences in TAT are due to combinations of 
cellular hyperplasia and hypertrophy, increasing adipose tissue is primarily explained by 
hypertrophy, i.e. an increased FM fraction per adipocytes.7,8 Hypertrophy is then associated 
with increased secretion of pro-inflammatory cytokines9 and is supposed to result in the 
development of metabolic risks, e.g. insulin resistance.10,11 Therefore, the relationship between 
FM and TAT as a fat fraction per adipose tissue may influence on metabolic risks.  
In the present study we have used in vivo body composition data on FM (as assessed by either 
4C or QMR) and TAT (as assessed by MRI) to assess their associations as well as their relation 
to metabolic risk in normal-, overweight and obese adults. The aims of this study were (i) to 
investigate the association between FM and TAT in a large study population in vivo and (ii) to 
analyze possible associations of the FM/TAT ratio to metabolic risks independent of FM and 
TAT. We hypothesized that due to inter-individual variance in the FM/TAT ratio, FM and TAT 
cannot be used interchangeably.  
 
Materials and Methods 
Subjects 
We have analyzed data of 377 healthy Caucasian adults aged 18-60 years [body mass index 
(BMI): 25.6 (22.8-31.1) kg/m²; women: 51.2%] who had participated in different studies at the 
“Reference Centre for Body Composition” (Institute of Human Nutrition and Food Science at 
the University of Kiel, Germany) between 2005 and 2016. Exclusion criteria were pregnancy, 
acute or chronic diseases, medication intake, smoking and metallic implants. Subjects were 
recruited by notice board postings and by local advertisements. In children, adolescents and 
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adults, measurements of anthropometry, FM and metabolic variables were performed at the 
Institute of Human Nutrition and Food Science (University of Kiel), whereas total and regional 
adipose tissue were assessed at the MRI-unit of the Clinic of Radiology at the University 
Hospital Schleswig Holstein on an additional date. In an independent group (48 Caucasian 
adults aged 20-69 years; BMI: 25.0 (22.6-38.9) kg/m²) we analyzed data on liver fat to 
investigate the association to fat fraction per adipose tissue. Written informed consent was 
obtained from each subject before participation. All studies were conducted according to the 
guidelines laid down in the “Declaration of Helsinki” and approved by the ethical committee 
of the department of medicine of Christian-Albrechts-University Kiel. 
 
Anthropometric measurements 
Body height was determined with participants wearing no shoes to the nearest 0.5 cm by using 
a stadiometer (SECA, Modell 220, Hamburg, Germany). Body weight was assessed to the 
nearest 0.01 kg using an electronic scale (Tanita, Tokyo, Japan). Waist circumference (WC) 
was measured midway between the lowest rib and the top of the iliac crest at the end of a normal 
expiration with the subjects standing in upright position. The measurement was done with a 
non-elastic plastic tape positioned parallel to the floor. 
 
4-compartment model 
FM and fat-free mass (FFM) were determined using a 4C model as has been described in detail 
before.12 Briefly, the model divided the body into lipids, water, mineral and protein content. 
Body mineral content (BMC) was measured by dual X-ray absorptiometry (DXA), body 
volume by air-displacement plethysmography (ADP) and total body water (TBW) by deuterium 
oxide dilution. The following equation was used to determine FM4C: 
FM4C (kg) = 2.747 x body volumeADP (l) – 0.710 x TBW (l) + 1.460 x BMCDXA (kg) –  
2.050 x body weight (kg).13 
FFM4C (kg) was then calculated as body weight (kg) – FM4C (kg). FM4C-Index (FMI4C) was 
calculated as FM4C (kg) / body height (m)². Further, FM4C/FFM4C ratio was used as a measure 
of metabolic load related to metabolic capacity.14 
 
Quantitative magnetic resonance 
FM was also determined by non-invasive QMR (EchoMRI; Echo Medical Systems LLC, 
Houston, TX, USA) as in detail described elsewhere.15,16 Briefly, subjects were examined in 
supine position without wearing any metallic clothing items. Overall, the measurement last for 
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six minutes and the mean of three measurements was calculated. Quantification of FMQMR is 
based on Carr-Purcell-Meiboom-Gill-sequence.17 FFMQMR is then calculated as the difference 
between body weight (kg) and FMQMR. 
 
Magnetic resonance imaging 
Volumes of TAT, SAT and VAT as well as liver fat content were measured by using whole-
body MRI with a 1.5T scanner (Magnetom Vision or Magnetom Avanto, Siemens Medical 
Systems, Erlangen, Germany) as has been described in detail before.18–21 Briefly, subjects were 
examined with their arms extended above their heads in a dorsal position. TAT was defined 
from wrist to ankle. VAT was assessed from femoral heads to the top of the liver. Volumes of 
SAT and VAT were segmented by using semi-manual segmentation software (SliceOmatic 4.3, 
Tomovision, Montreal, Canada). Masses of SAT and VAT were calculated as tissue volumes 
multiplied by density (0.923 g/cm³). TAT was calculated as SAT + VAT. Further, VAT/SAT 
ratio was determined as a measure of relative size of the intra-abdominal fat depots. TAT-Index 
(TATI) was calculated as TAT (l) / body height (m)². Liver fat was determined by a 2-point 
Dixon method using ImageJ software (US NIH, Bethesda, MD, USA). The quantity of liver fat 
was assessed as percentage of the total liver core.  
 
Fat fraction per adipose tissue 
The fat fraction per adipose tissue was defined as the ratio of FM (kg) / TAT volume (l). We 
assumed that physiologically the proportion by weight of FM in adipose tissue is approximately 
80%.3–5 We also compared groups differing in FM/TAT (low, normal, high). According to 
literature-based values, normal FM/TAT was defined as 0.62 ≤ FM/TAT ≤ 0.91, low as 
FM/TAT < 0.62, and high as FM/TAT > 0.91).3 
 
Resting energy expenditure 
As a part of metabolic risk assessment, resting energy expenditure (REE) and respiratory 
quotient (RQ) were determined by indirect calorimetry using an open-circuit ventilated-hood 
system (Vmax Spectra 29n, SensorMedics BV, Viasys Healthcare, Bilthoven, Netherlands; 
software V-max version 12-1A) as in detail described elsewhere.22 Briefly, indirect calorimetry 
was conducted in the morning after an overnight fast with the measurement taking at least 45 
min. The first 10 min of each measurement was rejected. The coefficient of variation for 
repeated measurements was 5.0%.23 REE was further adjusted for FFM (REEFFM) using 
regression analysis.24 
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Metabolic traits 
Blood samples were taken at least 8-h postprandially and analyzed by standard procedures. 
Plasma glucose and TG were determined enzymatically using Konelab-Test-Kit (Thermo 
Clinical Labsystems, Frankfurt, Germany). Plasma insulin and plasma leptin were measured by 
radioimmunoassay (Adaltis, Freiburg, Germany; Linco Research, St Charles, MO, USA). C-
reactive protein (CRP) was measured by using latex-agglutination (CRP-Dynamik/Hit917, 
BIOMED Labordiagnostik GmbH Oberschleißheim, Germany). Homeostasis model 
assessment of insulin resistance (HOMA-IR) was used to determine insulin resistance:  
HOMA-IR = plasma glucose (mmol/L) x plasma insulin (µU/ml) / 22.5 (ref. 25) 
 
Statistical analysis 
All statistical analyses were performed with SPSS statistical software (SPSS 24.0, Inc., 
Chicago, Illinois, USA). Data are given as median and inter-quartile range (IQR). Mann-
Whitney U test and Kruskal-Wallis test with Bonferroni correction were performed for 
differences between groups. Further analysis were stratified by gender because of significant 
differences in body composition and metabolic risks. According to literature-based values of 
fat fraction per adipose tissue, associations between parameters of body composition and 
metabolic traits were examined by bivariate correlations and stepwise multivariate regression 
analyses in men and women within a normal range of FM/TAT (FM/TAT: 0.62-0.91).3 
Residuals of leptin, HOMA-IR, CRP and TG regressed on FM4C were calculated by linear 
regression analysis and related to FM4C/TAT. In gender-specific multivariate regression 
analyses, leptin, HOMA-IR, CRP and TG were included as dependent variables with either age, 
FMI4C and FM4C/TAT (Model 1) or age, TATI and FM4C/TAT (Model 2) as independent 
variables.  Regression analyses were corrected for multiple testing using the false discovery 
rate based on Benjamini and Hochberg procedure at a level of 5%.26 All tests were two-sided 
and level of significance was set at P < 0.05. 
 
Results 
The main characteristics of the study population are shown in Table 1. 54.4% of women and 
54.3% of men were overweight or obese. FM4C, FMQMR, FMI4C, FM4C/FFM4C, TAT, TATI, 
SAT, leptin, insulin, HOMA-IR and CRP were significantly greater in women than in men. By 
contrast, body weight, WC, FFM4C, FFMQMR, VAT, VAT/SAT, REE and REEFFM were greater 
in men. 
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 Table 1. Characteristics of the study population stratified by gender  
  N Women  N Men  
 Age (y) 193 35a (26 – 44)  184 33 (26 – 44)  
 Body weight (kg) 193 75.6 (64.6 – 90.9)***  184 84.9 (75.3 – 96.2)  
 BMI ≥ 25 (%) 193 54.4  184 54.3  
 BMI (kg/m²) 193 25.6 (22.5 – 32.8)  184 25.5 (23.0 – 29.4)  
 WC (cm) 193 88.0 (77.0 – 102.5)**  184 90.3 (83.3 – 104.3)  
 FM4C (kg) 193 25.4 (18.7 – 37.6)***  144 20.3 (13.4 – 27.1)  
 FMQMR (kg) 26 38.5 (24.1 – 52.9)***  72 15.3 (11.1 – 29.7)  
 FFM4C (kg) 193 48.7 (44.1 – 55.2)***  144 68.0 (61.7 – 72.4)  
 FFMQMR (kg) 26 50.3 (41.2 – 54.7)***  72 64.7 (59.3 – 69.0)  
 TBW (l) 193 36.2 (32.7 – 40.8)***  144 49.0 (45.0 – 52.3)  
 ICW (l) 178 20.3 (17.9 – 23.0)***  132 28.9 (26.6 – 31.1)  
 ECW (l) 178 14.7 (13.6 – 17.1)***  132 19.1 (17.7 – 20.7)  
 FMI4C (kg/m²) 193 8.9 (6.4 – 13.8)***  144 6.2 (4.1 – 8.4)  
 FM4C/FFM4C 193 0.53 (0.41 – 0.73)***  144 0.30 (0.22 – 0.40)  
 TAT (l) 193 30.0 (21.8 – 43.4)***  184 20.6 (14.8 – 29.4)  
 TATI (l/m²) 193 9.9 (7.0 – 14.5)***  184 6.0 (4.1 – 8.3)  
 FM4C/TAT (kg/l) 193 0.86 (0.79 – 0.94)  144 0.84 (0.74 – 0.95)  
 SAT (kg) 193 20.0 (17.2 – 35.4)***  184 14.9 (11.4 – 20.4)  
 VAT (kg) 192 1.4 (0.7 – 2.3)***  183 2.2 (1.1 – 4.6)  
 VAT/SAT 192 0.05 (0.04 – 0.08)***  183 0.14 (0.09 – 0.21)  
 Leptin (ng/ml) 118 17.3 (9.8 – 36.3)***  111 3.5 (2.1 – 6.8)  
 Insulin (µU/ml) 181 10.6 (7.0 – 18.5)**  173 8.4 (6.5 – 13.7)  
 HOMA-IR 181 2.4 (1.6 – 4.4)**  173 1.9 (1.4 – 3.3)  
 CRP 128 1.2 (0.5 – 2.9)**  99 0.8 (0.3 – 1.6)  
 Triglycerides (mg/dl) 190 92 (71 – 138)  171 102 (76 – 143)  
 REE (kcal/d) 190 1500 (1367 – 1666)***  175 1878 (1726 – 2044)  
 REEFFM (kcal/d) 190 1531 (1444 – 1622)***  136 1895 (1780 – 1998)  
 RQ 173 0.83 (0.79 – 0.87)  120 0.83 (0.79 – 0.87)  
 
Abbreviations: 4C, four-compartment model; CRP, C-reactive protein; ECW, extracellular water; FFM, 
fat-free mass; FM, fat mass; FMI, fat mass index; ICW, intercellular water; QMR, quantitative magnetic 
resonance; REE, resting energy expenditure; REEFFM, resting energy expenditure adjusted for fat-free 
mass; RQ, respiratory quotient; SAT, subcutaneous adipose tissue; TAT, total adipose tissue; TATI, total 
adipose tissue index; TBW, total body water; VAT, visceral adipose tissue; WC, waist circumference. 
aMedian (IQR) (all such values). 
*women significantly different from men, P < 0.05; **women significantly different from men, 
P < 0.01; ***women significantly different from men, P < 0.001 (Mann-Whitney U test). 
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Association between fat mass and total adipose tissue 
TAT was closely associated with FM (Figure 1A and 1B). This was independent of the method 
used to assess FM. There was a considerable inter-individual variance in FM/TAT, which was 
independent of FM as well as the method used to assess FM (Figure 1C and 1D). FM4C was 
closely associated with FMQMR (Figure S1). However, differences in FM between these 
methods were significant (data not shown).  
 
Association of fat mass per adipose tissue with body composition and metabolic traits 
Body composition, metabolic traits and REE were characterized in three groups with different 
FM4C/TAT-ratio (Table 2). When compared to men, the proportion of women was greater in 
the normal and high FM4C/TAT-groups than in the low FM4C/TAT-group. BMI, WC, FM4C, 
FMI4C, FM4C/FFM4C, TAT, TATI, SAT and leptin were greater in normal- and high FM4C/TAT-
groups than in the low FM4C/TAT-group. By contrast, FFM4C was lower in high FM4C/TAT 
than in low- and normal FM/TAT-groups. Restricting this analysis to normal weight subjects 
only, the associations of FM4C/TAT to BMI, WC and REEFFM lost significance (Table S1). 
 
Associations of FM4C/TAT with FM4C/FFM4C, VAT/SAT and liver fat are shown in Figure 2. 
There was a sex-difference in the associations. FM4C/TAT was stronger associated with 
FM4C/FFM4C in men than in women (Figure 2A). By contrast, FM4C/TAT was not significantly 
associated with VAT/SAT and liver fat in both genders (Figure 2B and 2C). 
  
  
  
Figure 1. Association between TAT and either FM4C (A) or FMQMR (B) or FM4C/TAT (C) or FMQMR/TAT (D) stratified by gender. Abbreviations: 4C, four-compartment model; 
FM, fat mass; QMR, quantitative magnetic resonance; TAT, total adipose tissue. solid line (Figure 1A and 1B) = regression line of total population; dashed line (Figure 1C and 
1D) = fat content (kg) as 0.8 of adipose tissue (l); solid lines (Figure 1C and 1D) = range of normal fat content (kg) of adipose tissue (l) (3–6) 
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Table 2. Descriptive characteristic of body composition, metabolic traits and resting energy 
expenditure stratified by different FM4C/TAT-groups 
 
  FM/TAT    
 Groupsa: < 0.62 0.62 – 0.91 > 0.91  p-value  
 N 12 208 117    
 Women (%) 8.3 58.7 59.8    
 Age (y) 29
b 
(27 – 36) 
36 
(26 – 43) 
37 
(28 – 49) 
 0.085  
 BMI (kg/m²) 23.0 
(22.1 – 25.2) 
26.2 
(23.1 – 31.7) 
26.8 
(23.6 – 34.1) 
 0.020  
 WC (cm) 79.5 
(75.0 – 86.0) 
91.0 
(81.0 – 104.9) 
94.5 
(82.0 – 106.0) 
 0.010  
 FM4C (kg) 
7.1 
(6.1 – 9.6) 
21.6 
(15.7 – 32.3) 
25.5c 
(19.7 – 37.8) 
 <0.001  
 FMI4C (kg/m²) 
2.3 
(1.9 – 3.0) 
7.1 
(5.2 – 10.8) 
8.6 
(6.5 – 13.4) 
 <0.001  
 FFM4C (kg) 
67.8 
(60.5 – 72.1) 
58.0 
(48.7 – 68.3) 
54.0c 
(46.1 – 64.8) 
 0.003  
 FM4C/FFM4C 
0.11 
(0.09 – 0.14) 
0.39 
(0.28 – 0.56) 
0.48c 
(0.38 – 0.70) 
 <0.001  
 TBW (l) 49.2 
(44.0 – 51.3) 
42.5 
(36.0 – 49.4) 
39.2 
(34.4 – 48.0) 
 0.012  
 ICW (l) 31.0 
(27.6 – 32.9) 
24.8 
(20.4 – 29.3) 
21.9c 
(18.8 – 27.9) 
 <0.001  
 ECW (l) 18.1 
(16.2 – 18.4) 
16.4 
(14.3 – 18.8) 
17.7c 
(14.5 – 20.3) 
 0.032  
 FM4C/TAT (kg/l) 
0.55 
(0.45 – 0.58) 
0.80 
(0.74 – 0.85) 
1.0 
(0.94 – 1.06) 
 <0.001  
 TAT (l) 15.9 
(10.7 – 19.1) 
28.6 
(10.1 – 40.9) 
26.0 
(20.4 – 37.4) 
 <0.001  
 TATI (l/m²) 4.7 
(3.2 – 5.6) 
8.6 
(6.1 – 12.9) 
8.2 
(6.1 – 11.6) 
 <0.001  
 SATtotal (kg) 
11.8 
(8.6 – 13.8) 
20.4 
(14.9 – 30.4) 
19.8 
(15.8 – 30.1) 
 <0.001  
 VAT (kg) 0.85 
(0.73 – 2.82) 
1.85 
(1.02 – 3.74) 
1.98 
(0.86 – 2.94) 
 0.282  
 Leptin (ng/ml) 2.0 
(1.3 – 2.9) 
11.9 
(5.0 – 28.2) 
11.2 
(7.6 – 19.4) 
 <0.001  
 HOMA-IR 1.9 
(1.5 – 2.8) 
2.4 
(1.6 – 4.3) 
2.1 
(1.4 – 4.0) 
 0.234  
 CRP 0.5 
(0.1 – 0.8) 
0.9 
(0.3 – 2.8) 
1.1 
(0.4 – 1.8) 
 0.260  
 Triglyceride (mg/dl) 87 
(74 – 116) 
95 
(77 – 142) 
100 
(71 – 139) 
 0.608  
 REE (kcal/d) 1748 
(1616 – 1867) 
1638 
(1468 – 1891) 
1673 
(1433 – 1966) 
 0.533  
 REEFFM (kcal/d) 
1749 
(1624 – 1814) 
1584 
(1464 – 1792) 
1668c 
(1553 – 1969) 
 0.001  
 RQ 0.84 
(0.80 – 0.85) 
0.83 
(0.79 – 0.87) 
0.83 
(0.80 – 0.88) 
 0.799  
 
Abbreviations: 4C, four-compartment model; CRP, C-reactive protein; ECW, extracellular water; FFM, fat-free mass; 
FM, fat mass; FMI, fat mass index; ICW, intercellular water; REE, resting energy expenditure; REEFFM, resting energy 
expenditure adjusted for fat-free mass; RQ, respiratory quotient; SAT, subcutaneous adipose tissue; TAT, total adipose 
tissue; TATI, total adipose tissue index; TBW, total body water; VAT, visceral adipose tissue; WC, waist circumference. 
alow: FM/TAT < 0.62; normal: 0.62 ≤ FM/TAT ≤ 0.91; high: FM/TAT > 0.91. 
bMedian (IQR) (all such values). 
 p-values, differences between FM/TAT groups (Kruskal-Wallis test with bonferroni correction). 
csignificant differences between normal- and high FM/TAT-group. 
 
  
      
Figure 2. Association between FM4C/TAT and either ratio of FM/FFM (A) or VAT/SAT (B) or liver fat (C) stratified by gender. Liver fat was analysed in an independent group 
of 48 subjects (women: BMI 46.4 (41.9 – 53.4) kg/m²; men: 23.3 (22.2 – 30.6) kg/m²). Abbreviations: 4C, four-compartment model; FM, fat mass; FFM, fat-free mass; SAT, 
subcutaneous adipose tissue; TAT, total adipose tissue; VAT, visceral adipose tissue. Dashed lines = women; solid lines = men 
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Association between fat mass per adipose tissue and metabolic risk independent of fat mass 
Bivariate correlations between FM4C, FMI4C, TAT, TATI, FM4C/TAT and metabolic traits are 
shown in Table 3. In both genders, positive associations were found of FM4C and TAT with 
leptin, insulin, HOMA-IR, CRP and TG. Similar associations between either FM4C or TAT 
adjusted for height (FMI4C and TATI) and metabolic traits were found. The associations 
between FM4C/TAT and leptin and CRP were weaker when compared with either FM4C or 
FMI4C or TAT or TATI. 
Inverse association between FM4C/TAT and residuals of leptin and HOMA-IR regressed on 
FM4C were seen in men (data not shown). In women, there were no associations between 
FM4C/TAT and residuals of metabolic traits regressed on FM4C. 
Using stepwise multivariate regression analysis, FMI4C and TATI were the major predictors of 
metabolic risks (Table 4). Accordingly, their explained variances of leptin, HOMA-IR, CRP 
and TG were similar in either women or men. The strongest association was found between 
FMI4C and plasma leptin. 62.7% or 61.8% of the variance in leptin in women and men, 
respectively, were explained by FMI4C. In addition, FMI4C or TATI explained up to 39.3% of 
the variance in HOMA-IR and CRP. Independent of FMI4C or TATI, FM4C/TAT added to the 
variance of leptin and CRP. Accordingly, greater FM4C/TAT was associated with higher plasma 
leptin and lower CRP. Using age, whole body extra- and intracellular water as independent 
variables, did not add to explain the variance in FM4C/TAT (data not shown). 
  
 
 Table 3. Bivariate correlations between FM4C, FMI4C, TAT, TATI, FM4C/TAT and metabolic traits stratified by gender  
  Correlation coefficient (r)a  
  Women  Men  
  FM4C  FMI4C TAT TATI FM4C/TAT  FM4C FMI4C TAT TATI FM4C/TAT  
 Leptin 0.869*** 0.864*** 0.868*** 0.858*** 0.206*  0.814*** 0.819*** 0.838*** 0.820*** 0.067  
 Insulin 0.372*** 0.357*** 0.381*** 0.366*** -0.053  0.668*** 0.667*** 0.684*** 0.675*** -0.133  
 HOMA-IR 0.355*** 0.340*** 0.367*** 0.352*** -0.067  0.680*** 0.684*** 0.699*** 0.693*** -0.150  
 CRP 0.553*** 0.572*** 0.579*** 0.593*** -0.183  0.433** 0.445*** 0.515*** 0.524*** -0.317*  
 TG 0.337*** 0.329*** 0.337*** 0.333*** -0.032  0.438*** 0.467*** 0.493*** 0.510*** -0.214  
 Abbreviations: 4C, four-compartment model; CRP, C-reactive protein; FM, fat mass; FMI, fat mass index; TAT, total adipose tissue; TATI, total adipose tissue index; TG, 
triglycerides. 
abased on data with FM/TAT between 0.62 and 0.91 (ref. 3) 
*significant correlation, P < 0.05; **significant correlation, P < 0.01; ***significant correlation, P < 0.001. 
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 Table 4. Stepwise multivariate linear regression with leptin, HOMA-IR, CRP and triglycerides as dependent variables  
  Leptin
a  HOMA-IRa  CRPa  TGa  
  R² β p-value  R² β p-value  R² β p-value  R² β p-value  
 Women
b         
 n 101  118  78  120  
 Age (y) 1.8 -0.145 0.027  3.1 -0.195 0.032  0.0 -0.190 0.065  0.0 -0.143 0.162  
 FMI4C (kg/m²) 62.7 0.815 <0.001  17.3 0.453 <0.001  32.8 0.608 <0.001  8.0 0.296 0.003  
 FM4C/TAT (kg/l) 0.0 0.069 0.259  0.0 -0.065 0.441  0.0 -0.157 0.092  0.0 -0.060 0.502  
 Age (y) 1.4 -0.135 0.024  3.1 -0.195 0.032  0.0 -0.190 0.065  0.0 -0.142 0.167  
 TATI (l/m²) 61.1 0.800 <0.001  18.0 0.460 <0.001  33.6 0.614 <0.001  7.9 0.294 0.003  
 FM4C/TAT (kg/l) 3.9 0.201 0.002  0.0 0.012 0.888  0.0 -0.051 0.575  0.0 -0.010 0.913  
 Men
b         
 n 59  82  62  83  
 Age (y) 10.4 -0.344 <0.001  0.0 -0.153 0.100  0.0 0.108 0.384  0.0 0.055 0.601  
 FMI4C (kg/m²) 61.8 0.894 <0.001  36.7 0.612 <0.001  10.8 0.371 0.006  18.1 0.437 <0.001  
 FM4C/TAT (kg/l) 0.0 0.059 0.398  0.0 -0.154 0.125  5.9 -0.269 0.038  0.0 -0.128 0.305  
 Age (y) 10.2 -0.351 <0.001  0.0 -0.162 0.113  0.0 0.116 0.361  0.0 0.053 0.902  
 TATI (l/m²) 59.3 0.929 <0.001  39.3 0.633 <0.001  11.7 0.362 0.012  18.4 0.440 <0.001  
 FM4C/TAT (kg/l) 7.7 0.284 <0.001  0.0 0.001 0.994  0.0 -0.184 0.198  0.0 -0.020 0.843  
 Abbreviations: 4C, four-compartment model; CRP, C-reactive protein; FMI, fat mass index; TATI, total adipose tissue index; TG, triglycerides. 
abased on data with FM4C/TAT between 0.62 and 0.91 (ref. 3) 
btwo models were conducted: Model 1 includes age, FMI4C and FM4C/TAT as independent variables; Model 2 includes age, TATI and FM4C/TAT as independent variables. 
p-value = corrected for multiple testing by controlling the false discovery rate. 
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Discussion 
Either the 4C-model or QMR to determine FM and MRI to determine TAT are the gold-standard 
methods of body composition analysis. FM is assumed to account for 80% of TAT. However, we 
found a considerable inter-individual variation in the FM/TAT association. Further, inter-
individual variation in the associations between either FM or TAT and metabolic traits were seen.27 
The variation in the FM/TAT ratio question the idea that FM and TAT can be used interchangeably 
to assess body composition associated metabolic risk in a large population of normal-, overweight 
and obese subjects. 
 
Association between fat mass and total adipose tissue 
There was a strong association between FM and TAT (Figure 1A and 1B). This is in line with 
previous findings.3 However, considerable inter-individual variation of FM/TAT ratio were seen 
(IQR: FM4C/TAT: 0.77-0.94; FMQMR/TAT: 0.89-1.10) (Figure 1C and 1D). Our data indicated that 
in this population of adults FM regressed on TAT is neither constant nor dependent on adiposity. 
This is in line with other biopsy studies showing a wide variability of fat fraction of adipose tissue 
ranging between 0.62 and 0.91. (refs. 3–6) 
 
Association between fat mass per adipose tissue, body composition and metabolic traits 
FM4C/TAT was positively related to BMI, WC, FM4C, FMI4C, FM4C/FFM4C and leptin. By 
contrast, it was inversely associated with FFM4C (Table 2). FM4C/FFM4C may be used as a measure 
of metabolic load divided by metabolic capacity with decreasing metabolic capacity as FM/FFM 
increases.14 Thus, increasing FM4C/TAT would lead to further decreased metabolic capacity. FM4C 
was significantly higher in high FM4C/TAT-group than in normal FM4C/TAT-group, whereas TAT 
was lower in high FM4C/TAT-group than in normal FM4C/TAT-group (Table 2). Accordingly, 
FM4C/TAT is positively related to age. These findings would suggest that with increasing age a 
higher amount of FM is deposited in ectopic depots, e.g. liver, pancreas and or skeletal muscle. 
This is line with the finding that FM4C/TAT was associated with regional fat depots. FM4C/TAT 
showed a positive tendency to liver fat in both genders (Figure 2C). 
 
Association between fat mass per adipose tissue and metabolic risk independent of fat mass and 
adipose tissue 
FM4C/TAT was associated with plasma leptin and CRP (Table 3). Variances of leptin, HOMA-IR, 
CRP and TG were similarly explained by FMI4C or TATI (Table 4). This could be due to almost 
equal associations between either FMI4C or TATI and metabolic traits (Table 3). However, we 
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found evidence for a FM-independent association of FM4C/TAT with metabolic risk. After 
adjustment for TATI, FM4C/TAT added to the variance of leptin; greater FM4C/TAT was 
associated with higher plasma leptin (Table 4). In addition, after adjustment for FMI4C, FM4C/TAT 
added to the variance of CRP. However, after adjustment for FMI4C or TATI, there were no 
relationships in leptin or CRP, respectively (Table 4). With regard to fat mass and fat volume, our 
findings indicated that FM4C and TAT cannot be used interchangeably to assess metabolic risk in 
normal-, overweight and obese adults. Both variables may add to metabolic risk assessment. It 
should be mentioned that previous data have shown an FM-independent direct association between 
adipocyte size and insulin resistance in overweight and obese subjects.28,29 Since however, in our 
studies we were not allowed to do fat biopsies for ethical reason the association between 
FM4C/TAT and the size of adipocytes remains to be shown. 
 
Study Strengths and Limitations 
This study took advantage of access to detailed specific measurement of both FM and TAT in the 
same individuals allowing investigation of the associations between FM/TAT, body composition 
and metabolic risk in normal-, overweight and obese subjects. In addition, FM was measured by 
two independent gold-standard methods (4C-model and QMR) and divided by TAT determined 
by whole-body MRI. Limitations of the present study include the lack of adipose tissue biopsies, 
data on liver fat of only a subgroup, and the cross-sectional study design prohibiting assessment 
of the dynamic relationships between FM/TAT and changes over time in body composition and 
metabolic risk. 
 
Conclusion 
Although FM and TAT were strongly correlated, there is a considerable inter-individual variance 
in FM/TAT-ratio, which is independent of adiposity measured by FM. Independent of FMI or 
TATI, FM/TAT added to the variance of leptin and CRP. Therefore, the interchangeable use of 
FM and TAT to assess metabolic risks is questionable. However, both parameters may 
complement each other, and their respective physiological roles need to be elucidated. 
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    Figure S1. Association between fat mass assessed by four-compartment  
    model and fat mass assessed by quantitative magnetic resonance.  
    Abbreviations: 4C, four-compartment model; QMR, quantitative magnetic  
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Table S1. Descriptive Characteristic of body composition, metabolic traits and resting 
energy expenditure stratified by different FM/TAT groups in adults with BMI ≤ 27.5 
 
  FM/TAT    
 Groupsa: < 0.62 0.62 – 0.91 > 0.91  p-value  
 N 11 115 66    
 Female (%) 9.1 54.8 68.2    
 Age (y) 28
b 
(26 – 32) 
31 
(26 – 42) 
39 
(28 – 51) 
 0.003  
 BMI (kg/m²) 22.6 
(22.0 – 24.7) 
23.3 
(21.5 – 25.1) 
24.0 
(22.1 – 25.6) 
 0.218  
 WC (cm) 79.0 
(75.0 – 86.0) 
81.5 
(75.0 – 89.0) 
83.3 
(78.0 – 92.0) 
 0.112  
 FM4C (kg) 
6.4 
(6.0 – 8.5) 
16.5 
(12.4 – 20.5) 
20.5 
(17.5 – 23.8) 
 <0.001  
 FMI4C (kg/m²) 
2.2 
(1.9 – 2.5) 
5.4 
(4.0 – 6.6) 
6.8 
(5.5 – 7.7) 
 <0.001  
 FFM4C (kg) 
67.8 
(59.6 – 71.8) 
52.8 
(46.0 – 63.3) 
46.7 
(42.1 – 58.8) 
 <0.001  
 FM4C/FFM4C 
0.11 
(0.09 – 0.12) 
0.31 
(0.22 – 0.41) 
0.41 
(0.32 – 0.50) 
 <0.001  
 TBW (l) 48.0 
(43.2 – 51.1) 
38.8 
(33.5 – 45.5) 
35.1 
(31.0 – 42.2) 
 0.001  
 ICW (l) 29.9 
(26.7 – 32.8) 
22.8 
(19.1 – 27.9) 
20.1 
(17.1 – 24.6) 
 <0.001  
 ECW (l) 18.0 
(16.0 – 18.2) 
15.5 
(13.8 – 17.7) 
14.9 
(13.6 – 17.9) 
 0.203  
 FM4C/TAT (kg/l) 
0.52 
(0.43 – 0.58) 
0.80 
(0.75 – 0.85) 
0.96 
(0.93 – 1.01) 
 <0.001  
 TAT (l) 15.1 
(10.5 – 18.9) 
21.1 
(15.5 – 25.4) 
21.0 
(17.4 – 24.0) 
 0.002  
 TATI (l/m²) 4.5 
(3.0 – 5.5) 
6.4 
(4.7 – 8.0) 
6.4 
(5.5 – 7.7) 
 0.002  
 SATtotal (kg) 
11.7 
(8.6 – 12.7) 
16.4 
(11.8 – 19.9) 
16.1 
(13.9 – 19.3) 
 0.001  
 VAT (kg) 0.81 
(0.71 – 1.86) 
1.15 
(0.60 – 2.01) 
1.13 
(0.57 – 2.01) 
 0.781  
 Leptin (ng/ml) 1.8 
(1.3 – 2.8) 
5.7 
(3.4 – 12.3) 
8.8 
(6.7 – 12.2) 
 0.001  
 HOMA-IR 1.8 
(1.5 – 2.8) 
2.0 
(1.5 – 3.1) 
1.5 
(1.1 – 2.1) 
 0.002  
 CRP 0.2 
(0.1 – 0.8) 
0.5 
(0.2 – 1.5) 
0.9 
(0.3 – 1.7) 
 0.171  
 Triglyceride (mg/dl) 88 
(71 – 127) 
85 
(71 – 112) 
96 
(67 – 132) 
 0.803  
 REE (kcal/d) 1743 
(1597 – 1879) 
1497 
(1371 – 1735) 
1470 
(1343 – 1701) 
 0.042  
 REEFFM (kcal/d) 
1759 
(1677 – 1820) 
1579 
(1452 – 1786) 
1566 
(1460 – 1826) 
 0.199  
 RQ 0.85 
(0.80 – 0.85) 
0.82 
(0.79 – 0.87) 
0.83 
(0.79 – 0.85) 
 0.660  
 
Abbreviations: 4C, four-compartment model; CRP, C-reactive protein; ECW, extracellular water; FFM, fat-free mass; FM, 
fat mass; FMI, fat mass index; ICW, intercellular water; REE, resting energy expenditure; REEFFM, resting energy 
expenditure adjusted for fat-free mass; RQ, respiratory quotient; SAT, subcutaneous adipose tissue; TAT, total adipose 
tissue; TATI, total adipose tissue index; TBW, total body water; VAT, visceral adipose tissue; WC, waist circumference. 
alow: FM/TAT < 0.62; normal: 0.62 ≤ FM/TAT ≤ 0.91; high: FM/TAT > 0.91. 
bMedian (IQR) (all such values). 
 p-values, differences between different FM/TAT groups (Kruskal-Wallis test with bonferroni correction). 
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Summary of study rationale and objectives 
During the last decades, the prevalence of overweight an obesity increased in all age- and sex 
groups. However, these numbers depend on an appropriate definition of overweight and 
obesity. In children, adolescents and adults, overweight and obesity are defined by BMI only. 
In adults, BMI cut-offs are associated with morbidity and mortality. By contrast, in children and 
adolescents the respective BMI cut-offs relate to normative analyses without a strict association 
with any health outcome. Thus, strictly spoken, the comparison of overweight and obesity 
between children, adolescents and adults is not possible.  
Since, (i) overweight and obesity are characterized by excessive fat accumulation which again 
(ii) is associated with cardiometabolic diseases [1], associations between anthropometric traits, 
detailed body composition and cardiometabolic risks have to be characterized in more detail 
and, particularly, there is need of a systematic analysis in children, adolescents and adults using 
identical methods, outcomes and statistical analyses. Accordingly, individuals with a risk-
related unfavorable body composition could be identified at an early stage.  
Our present knowledge about the relationship between detailed body composition and 
cardiometabolic risks is mainly based on studies on adults. By contrast, there is not much 
evidence about the associations between detailed body composition and cardiometabolic risks 
in children and adolescents. 
Therefore, the present thesis examined the associations between regional fat depots and 
cardiometabolic risks in normal- and overweight children, adolescents and adults (Chapter II). 
Further, detailed body composition based on either normative- or metabolic derived cut-offs 
were compared in different age groups (Chapter III). Taking different fat fraction per adipose 
tissue into account, we focused on FM and TAT, which are interchangeably used for metabolic 
risk assessment in clinical and research practice (Chapter IV). 
 
Regional fat depots and associated cardiometabolic risks in children, adolescents and adults 
Main findings and new issues of this thesis 
Whereas FM and SAT increased from childhood to adulthood, VAT remained low in children 
and adolescents with a considerable increase in young adults (Chapter II, Table 1). Comparing 
different age groups, associations between regional fat depots and most cardiometabolic risks 
became evident after puberty only (Chapter II, Table 2 and Table 3). When compared with FM 
adjusted for height, insulin resistance had a stronger association with SATtrunk and VAT 
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(Chapter II, Table 2 and Table 3). Addressing the BMI-independent role of regional fat depots 
on insulin resistance, the impact of SAT became evident after adolescence with VAT being the 
most important body fat depot in older adults only (Chapter II, Table 4). This is the first study, 
which systematically investigate age-related associations between regional fat depots, 
measured by the gold standard method whole-body MRI, and cardiometabolic risks in children 
and adolescents compared with adults. 
State of research 
Up to now, only limited data on the development of regional fat depots and their association 
with cardiometabolic risks in normal- and overweight children, adolescents and adults are 
available [2–5].  
DIFFERENCES IN REGIONAL FAT DEPOTS. Shen and colleagues were first to focus on detailed 
adipose tissue distribution in 5 to 88 years old subjects determined by whole-body MRI [5]. 
They observed that children had lower TAT, SATtotal, and VAT than adults. In addition, females 
had higher volumes of TAT and SAT than males in both age groups. By contrast, males had 
higher VAT volumes in adults only. However, due to changes in body composition and body 
fat distribution during pubertal development as well as during aging in adulthood [6–9], detailed 
body composition should be differentially investigated. We could confirm that regional fat 
depots were higher in adulthood than in childhood. Nonetheless, our results indicated that 
differences in regional fat depots between children and adolescents as well as young and older 
adults became apparent (Chapter II, Table 1). 
REGIONAL FAT DEPOTS ASSOCIATED WITH CARDIOMETABOLIC RISKS. Previous studies reported a 
decreased cardiometabolic risk with higher proportion of SATlegs in children, adolescents and 
adults [10–12]. This is contrary to our findings (Chapter II, Table 2). The discrepancy could be 
explained by body fat adjustment. Whereas Staiano and collegues investigated the association 
between cardiometabolic risks and leg fat in relation to total body fat [12], we examined these 
associations using masses of SATlegs without adjustment. 
Previous studies in children reported that FM and SATtotal had a stronger relationship to insulin 
resistance than VAT [13,14]. Although VAT was low in children and adolescents (Chapter II, 
Table 1) the explained variance of HOMA-IR by abdominal fat depots were moderately 
increased in children, adolescents, young and older adults when compared with FMI (Chapter 
II, Table 3). Samouda and collegues  also observed that adding either trunk/leg fat mass index 
or FMtrunk to total FM increased the explained variance of insulin resistance in children and 
adolescents [15]. However, in contrast to other authors, they did not differentiate between 
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SATtrunk and VAT [15–17]. Accordingly, SATtrunk and VAT were both associated with insulin 
resistance. This was independent of body fat or BMI percentile [16,17]. These findings are 
contrary to our results. Differences in regional fat depots on insulin resistance, independent of 
BMI were seen in young and older adults only (Chapter II, Table 4). Nonetheless, we used 
whole-body MRI to assess SATtrunk and VAT, whereas other authors determined VAT and 
SATtrunk by DXA or single slice MRI using appropriate modelling [16,17]. In line with our 
results, VAT independently influenced insulin resistance in adults, with no significant influence 
in children and adolescents [2]. 
 Outlook 
Our results indicated that associations between cardiometabolic risks and regional fat depots 
should be separately investigated in children, adolescents as well as young and older adults. 
When compared with FMI, SATtrunk and VAT increased the explained variance of insulin 
resistance. Most studies on regional fat depots have identified SATtrunk and VAT as independent 
predictors of insulin resistance [2,12,15–17]. Nevertheless, the role of VAT on insulin 
resistance, independent of BMI, is apparent in adults only and therefore may describe a potential 
dynamic process of VAT being increasingly essential of insulin resistance during aging. 
However, an investigation on 100 obese children determined truncal fat to significantly affected 
the development of non-alcoholic fatty liver disease [18]. Thus, the measurement of regional 
fat depots, especially SATtrunk and VAT, are important in clinical practice for cardiometabolic 
risk assessment in all age groups. For a better understanding of the dynamic process of VAT 
and insulin resistance, longitudinal studies from childhood to adulthood would be preferable. 
Detailed body composition based on normative- and metabolic derived cut-offs 
Main findings and new issues of this thesis 
Sensitivity of BMI to predict FM was high in all age groups, whereas specificity decreased from 
children to adults (Chapter III, Figure 1). With increasing BMI and WC, TAT, SATtotal, SATtrunk 
and VAT increased cubically in children and adolescents. By contrast, these associations were 
linear in young and older adults (Chapter III, Figure 2). In addition, TAT, SATtotal, SATtrunk and 
VAT increased from childhood to adulthood based on normative BMI or WC cut-offs (Chapter 
III, Table 2). When compared with the normative cut-offs, insulin resistance derived cut-offs of 
regional fat depots were lower in all age groups (Chapter III, Figure 2, Table 2). This is the first 
study to analyze and compare regional fat depots based on normative- and equal insulin 
resistance derived cut-offs in children, adolescents as well as young and older adults. 
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 State of research 
Up to now, data on a systematic investigation on associations between anthropometric traits 
and regional fat depots as assessed by whole-body MRI in normal- and overweight children, 
adolescents and adults are lacking. Further, this is the first study to compare masses of regional 
fat depots at either BMI- or WC- or insulin resistance derived cut-offs. Thus, based on the 
associations between regional fat depots and insulin resistance, normative cut-offs can be 
evaluated. 
SENSITIVITY AND SPECIFICITY. Zimmermann and collegues examined the capacity of BMI for 
FM prediction in 6-12 years old children [19]. In line with our results, specificity of BMI to 
predict FM was high. However, they determined a lower sensitivity, which is contrary to our 
findings (Chapter III, Figure 1). In addition, another study in adults found a low sensitivity and 
a high specificity [20]. Although our results partly differ from these studies, it can commonly 
be concluded that BMI is not an appropriate predictor of FM. 
ANTHROPOMETRIC TRAITS AND REGIONAL FAT DEPOTS. Previous studies examined the 
associations between anthropometric traits and regional fat depots in children, adolescents and 
adults separately [21–28].  A study in preschool children have found moderate associations 
between VAT and either BMI or WC (r = 0.39; r = 0.43 respectively) [21]. Moreover, moderate 
associations between anthropometric traits and VAT were seen in adolescents, whereas BMI 
and WC were stronger associated with TAT, SATtotal and SATtrunk [22–24]. Nevertheless, 
reported associations between anthropometric traits and regional fat depots were linear in 
children and adolescents. This is contrary to our findings showing that TAT, SATtotal, SATtrunk 
and VAT followed a cubic function with a steep increase at BMI and WC ≥ 1 SDS (Chapter 
III, Figure 2). In line with our results, Koren and collegues reported that VAT increased 
exponentially with increasing BMI or WC [25]. In adults, associations between anthropometric 
traits and either TAT or SATtotal or SATtrunk were stronger than with VAT [26,27]. Supporting 
our findings (Chapter III, Figure 2), these associations were linear in adulthood. 
ANTHROPOMETRIC TRAITS, REGIONAL FAT DEPOTS AND ASSOCIATED INSULIN RESISTANCE. In 
clinical practice, quick and easy to use methods for metabolic risk assessment are preferable. 
Therefore, associations between anthropometric traits, regional fat depots and insulin resistance 
were compared in previous studies, which have shown only moderate associations between 
regional fat depots and insulin resistance in all age groups [22,29,30]. Further, when compared 
with BMI, FMI improved the prediction of insulin resistance in adults with no improvements 
in children and adolescents [31–35]. Overall, strongest associations between anthropometric 
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traits, regional fat depots and insulin resistance were observed for VAT in children, adolescents 
and adults [2,22,36]. This is in line with our findings (Chapter III, Figure 3). However, our 
results indicated that insulin resistance, as assessed by HOMA-IR is not primarily determined 
by masses of regional fat depots. A possible explanation is that HOMA-IR most probably 
reflects hepatic insulin resistance [37], whereas the gold standard of insulin sensitivity, the 
euglycemic clamp technique, reflects peripheral glucose uptake [38]. Associations between 
body composition, HOMA-IR and euglycemic clamp technique are shown in Figure D1.  
   
Figure D1. Associations between FMI, HOMA-IR and M-value by euglycemic clamp 
technique in 20-41 years old adults. Data obtained from German Reference Centre for Body 
Composition, Kiel [39,40]. Abbreviations: HOMA-IR, homeostasis model assessment of 
insulin resistance; FMI, fat mass index. 
 
FMI equally explained the variance of HOMA-IR and M- value by euglycemic clamp technique 
(Figure D1 A and B). However, as seen in Figure D1 C and supported by previous studies, the 
association between HOMA-IR and M-value by euglycemic clamp technique is moderate 
[37,39,40]. Thus, the association between fat mass and insulin sensitivity also depends on the 
method used to assess insulin resistance.  
REGIONAL FAT DEPOTS ON NORMATIVE AND INSULIN RESISTANCE DERIVED CUT-OFFS. In clinical 
practice, optimal cut-offs for anthropometric traits that predict cardiometabolic risks are 
preferable. Therefore, previous studies focused on BMI and WC in regard to metabolic 
syndrome and cardiovascular diseases [41–43]. Performing a ROC analysis with elevated 
HOMA-IR (> 2.5) as the state variable and either BMI or WC as the test variable, we determined 
different cut-offs for BMI and WC in children, adolescents, young and older adults stratified by 
gender (Table D1). BMI and WC cut-offs differ between age- and sex groups and increased 
from childhood to adulthood. Comparing young and older adults, WC cut-offs differ strongly. 
However, in line with previous studies, optimal cut-offs of BMI and WC for elevated 
cardiometabolic risk prediction were lower than established BMI- and WC cut-offs for obesity 
and abdominal obesity. 
y = 1.0569e0.0574x
R² = 0.4256
0
1
2
3
4
5
6
7
8
0 10 20 30
H
O
M
A
-I
R
FMI
y = 0.014x2 - 0.6406x + 11.469
R² = 0.4686
0
2
4
6
8
10
12
14
16
0 10 20 30
M
-v
a
lu
e
 (
m
g
 k
g
-1
m
in
-1
)
FMI
y = -1.933ln(x) + 5.8294
R² = 0.5169
0
1
2
3
4
5
6
7
8
0 5 10 15 20
H
O
M
A
-I
R
M-value (mg kg-1 min-1)
A B C 
men 
women 
CHAPTER V   General discussion 
98 
 
 Table D1. Optimal cut-offs for BMI and WC for predicting elevated HOMA-IR (> 2.5) in 
children, adolescents, young adults and adults stratified by gender1 
 
 
 Children  Adolescents  Young adults  Adults  
 
 males females  males females  males females  males females  
 
BMI (kg/m²) 21.7 21.8  22.8 20.9  25.1 24.6  25.7 25.8  
 
WC (cm) 73.9 71.0  76.1 87.2  87.5 88.4  95.5 90.5  
 Abbreviations: BMI, body mass index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin 
resistance. 
1Based on data of subjects (6-60 y) of the German Reference Centre for Body Composition, Kiel [44]. 
 
By contrast, we developed an approach based on regional fat depots. Masses of TAT, SATtotal, 
SATtrunk and VAT, using BMI- and WC cut-offs, differed between age- and sex groups and 
increased from childhood to adulthood (Chapter III, Table 2). In addition, comparing cut-offs 
of masses of regional fat depots derived from anthropometric traits and insulin resistance gave 
considerably lower values for the latter calculation (Chapter III, Table 2).  
What do the new cut-offs mean for the population issue of childhood overweight? 
To answer this question, we used cross-sectional data of the Kiel Obesity Prevention Study 
(KOPS) [45]. Accordingly, we compared the prevalence of overweight and obesity as well as 
abdominal overweight and obesity taking into account normative-, FM- and metabolic derived 
cut-offs in children and adolescents (Table D2). FM derived cut-offs are based on the association 
between FM and either BMI-SDS (Chapter III, Figure I) or WC-SDS. With regard to the 
metabolic derived cut-off, we applied the calculated BMI and WC cut-offs based on the asso-
ciations between regional fat depots (TAT, VAT) and insulin resistance (Chapter III, Figure 2).  
 
Table D2. Prevalence of overweight and obesity using cross-sectional data of Kiel Obesity 
Prevention Study (KOPS) based on normative-, fat mass- and metabolic (HOMA-IR > 2.5) 
derived cut-offs stratified by age group1 
 
  Prevalence  
  Children  Adolescents  
  normative2 FM3 metabolic4  normative2 FM3 metabolic4  
 OW (OB) (%) 13.3 (5.2) 33.6 (6.5) 26.7  13.5 (4.6) 51.2 (17.5) 40.4  
 Abd. OW/OB (%) 37.5 (12.6) 51.2 (17.5) 27.2  34.4 (9.3) 49.5 (19.3) 60.4  
 
Abbreviations: FM, fat mass; OW, overweight; OB, obese; Abd., abdominal; BMI, body mass index; SDS, standard 
deviation score; WC, waist circumference; HOMA-IR, homeostasis model assessment of insulin resistance. 
1Based on cross-sectional data of the Kiel Obesity Prevention Study [45]. 
2Based on BMI-SDS [46] and WC-SDS [47] cut-offs for overweight and obesity. 
3Based on FM derived cut-offs for overweight and obesity. 
4No differentiation between overweight and obesity because BMI and WC were related to elevated HOMA-IR only 
 
CHAPTER V   General discussion 
99 
 
When compared with normative- and FM derived cut-offs, prevalence of obesity were 
substantially higher according to the metabolic derived cut-off. This is alarming, because 
subjects with insulin resistance would not be entirely detected by using either the normative- or 
FM derived approach. 
Outlook 
Obesity is defined as an excessive fat accumulation which impairs health [48]. Our results 
indicated that established BMI- or WC cut-offs in children, adolescents and adults inadequately 
define subjects with an elevated risk of insulin resistance. Therefore, anthropometric cut-offs 
being used in clinical practice should be revised with regard to metabolic health outcomes or 
even replaced by body fat measurements and regional fat depots taking into account their 
associations with metabolic disturbances. However, insulin resistance results from a 
multidimensional and dynamic process. Therefore, longitudinal data from birth to adulthood 
are needed to address this complexity. 
Fat fraction per adipose tissue 
Main findings and new issues of this thesis 
FM measured by either 4C-Model or QMR were strongly associated with TAT as assessed by 
MRI (Chapter IV, Figure 1 A and B). However, substantial inter-individual variance of 
FM/TAT-ratio was seen (Chapter IV, Figure 1 C and D). FM/TAT showed a positive tendency 
to liver fat (Chapter IV, Figure 2 C). Further, FM and TAT were equally associated with 
metabolic risks (Chapter IV, Table 3). Independent of FM or TAT, FM/TAT added to the 
variance of leptin and CRP (Chapter IV, Table 4). 
 State of research 
Up to now, FM and TAT have been used interchangeably with regard to metabolic risk 
assessment. This is the first study, which used in vivo body composition data to assess the 
associations between FM, TAT, FM/TAT and metabolic risks in normal-, overweight and obese 
adults.  
FAT FRACTION PER ADIPOSE TISSUE. In line with others [49,50], FM was strongly associated with 
TAT (Chapter IV, Figure 1 A and B). However, using adipose tissue biopsies, several studies 
have shown that fat fraction per adipose tissue differed strongly between individuals as well as 
between individuals’ fat depots [49–51]. Measured by in vivo body composition data on FM 
and TAT, our findings confirmed the inter-individual variance in fat fraction per adipose tissue 
CHAPTER V   General discussion 
100 
 
(Chapter IV, Figure 1 C and D). Moreover, FM/TAT was independent of adiposity. This is 
contrary to previous findings, showing a linear relationship between fat fraction per adipose 
tissue and body fatness [50]. These differences may be explained by the fact that they examined 
six male cadavers only. 
FAT FRACTION PER ADIPOSE TISSUE RELATED TO REGIONAL FAT DEPOTS. The fat fraction in 
adipocytes can be increased by G0/G1 switch regulatory protein 2 [52]. This promotes 
adipocyte hypertrophy due to restriction of triglycerides turnover. Hypertrophy in turn can 
cause fat accumulation in ectopic regions such as the liver and muscle [53,54]. This is in line 
with our results showing a positive tendency between FM/TAT and liver fat (Chapter IV, Figure 
2 C). However, our result were not significant, which can be due to the relatively small number 
of subjects with data on liver fat (n=48). 
ASSOCIATIONS BETWEEN FAT MASS, TOTAL ADIPOSE TISSUE, FAT FRACTION PER ADIPOSE TISSUE 
AND METABOLIC RISKS. Both, FM and TAT were equally associated with metabolic risks 
(Chapter IV, Table 3). Our results are in line with previous findings showing moderate to strong 
associations [2,9,55]. Further, significant associations between  FM/TAT and either leptin or 
CRP were observed (Chapter IV, Table 3) and partly supported by previous findings according 
to FM/TAT and leptin [9]. However, associations between FM/TAT and either insulin or 
HOMA-IR or CRP or TG have not been investigated yet. Thus, further studies are needed to 
confirm our results. 
FAT FRACTION PER ADIPOSE TISSUE IS INDEPENDENTLY ASSOCIATED WITH METABOLIC RISKS. 
Increased fat fraction per adipose tissue is accompanied by adipose tissue remodeling, i.e. 
hypertrophy [52]. Several studies indicated that hypertrophy leads to cardiometabolic diseases, 
which can also be seen in early childhood [56–60]. Independent of FM or TAT, FM/TAT as a 
measure of fat fraction per adipose tissue added to the variance of leptin and CRP (Chapter IV, 
Table 4). Therefore, FM/TAT may be used as measure of adipocyte size to additionally predict 
metabolic risks in children, adolescents and adults without undergoing adipose tissue biopsy. 
Since, we were not allowed to do fat biopsies for ethical reason the association between 
FM/TAT as a measure of adipocyte size and metabolic risks remains to be shown. 
 Outlook 
FM and TAT cannot be used interchangeably to assess metabolic risks, because fat fraction per 
adipose tissue differed strongly between individuals regardless of adiposity. However, both 
parameters may complement each other. In future studies, associations between FM/TAT and 
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adipocyte size should be investigated to verify if adipose tissue biopsy could be replaced 
through in vivo body composition analysis.  
 
Conclusion 
In children, adolescents and adults, overweight and obesity are defined by BMI only. In adults, 
BMI cut-offs are associated with mortality risk. By contrast, respective BMI cut-offs are not 
strictly associated with any health outcome in children and adolescents. Therefore, overweight 
and obesity cannot be compared between different age groups. Moreover, overweight and 
obesity are characterized by excessive fat accumulation, which in turn is related to 
cardiometabolic diseases. Consequently, there is need of a systematic investigation of 
anthropometric traits and detailed body composition related to cardiometabolic diseases in 
children, adolescents and adults by using identical methods, outcomes and analyses. This is the 
only approach to compare results in different age groups.  
Overall, the results of the present thesis show the limited value of anthropometric traits in 
children, adolescents and adults. This can be proved by means of detailed body composition 
and the associations between regional fat depots and cardiometabolic risks.  
Our findings demonstrate that associations between regional fat depots and most 
cardiometabolic risks became evident after puberty. Whereas VAT was the strongest predictor 
of insulin resistance in all age groups, insulin resistance was associated with VAT, independent 
of BMI, in adults only. 
Besides, associations between anthropometric traits and regional fat depots varied between 
children, adolescents and adults. When compared with insulin resistance derived cut-offs, BMI- 
and WC derived values led to higher masses of regional fat depots. Therefore, BMI- and WC 
cut-offs are not appropriate to determine metabolic risks. Instead, our new cut-offs of BMI and 
WC could be used. These are related to metabolic disorders in children, adolescents and adults 
equally. Otherwise, cut-offs of regional fat depots, which are directly associated with insulin 
resistance should be established. 
With regard to the final chapter, FM and TAT cannot be used interchangeably. Substantial inter-
individual variances in FM/TAT were seen. Independent of FM or TAT, FM/TAT added to the 
variance of metabolic risks. In future studies measurements of FM and TAT should be 
performed together because both parameters could complement each other. 
In summary, associations between regional fat depots and cardiometabolic risks differ between 
children, adolescents as well as young and older adults. In addition, established cut-offs of 
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anthropometric traits are not appropriate for metabolic risk assessment. Considering 
anthropometric traits, regional fat depots and HOMA-IR together, this would lead to a better 
characterization of treatable subjects. Further, FM and TAT cannot be used interchangeably. 
Nevertheless cardiovascular diseases result from a multidimensional dynamic process, which 
cannot be addressed in a cross-sectional study. Focusing on the dramatically increase in 
childhood obesity and its related diseases, longitudinal studies from early childhood to older 
adulthood are crucial. 
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SUMMARY 
In children, adolescents and adults, overweight and obesity are defined by body mass index 
(BMI) only. In adults, respective BMI cut-offs are associated with mortality risk. By contrast, 
in children and adolescents, established cut-offs are based on statistical normative analyses and 
are not directly related to any health outcome.  
Overweight and obesity are characterized by excessive fat mass (FM), which again is associated 
with cardiometabolic diseases. This association is not accurately represented by BMI. 
Accordingly, BMI can neither differentiate between FM and fat-free mass (FFM) nor give 
detailed information about body fat distribution. In addition, waist circumference (WC) does 
not distinguish between visceral and subcutaneous adipose tissue (VAT, SAT). Finally, there 
are differences in the association between BMI and morbidity between age groups. 
Within this thesis, the associations between anthropometric traits, detailed body composition 
and cardiometabolic risks in children, adolescents and adults are investigated and 
systematically compared. The results show the limited value of anthropometric traits in relation 
to regional fat depots and cardiometabolic risks. 
Within this thesis we investigated whether (i) associations between regional fat depots and 
cardiometabolic risks differ in normal- and overweight children, adolescents and adults, (ii) 
normative cut-offs of BMI and WC are appropriate for metabolic risk assessment when 
compared with directly measured regional fat depots and metabolic derived cut-offs and (iii) fat 
fraction per adipose tissue adds to metabolic risk assessment. 
The main results of this thesis are: 
(i) Associations between regional fat depots and cardiometabolic risks became evident after 
puberty only. Insulin resistance was strongest correlated with VAT. Independent of BMI, VAT 
was associated with insulin resistance in older adults only. 
(ii) When compared with metabolic derived values, normative cut-offs are not appropriate to 
define children, adolescents and adults with insulin resistance.  
(iii) FM and TAT were strongly correlated. However, substantial inter-individual variances in 
fat fraction per adipose tissue were found. Regarding this, fat fraction per adipose tissue added 
value to metabolic risk assessment independent of FM or TAT. 
These findings demonstrate the need for future differentiated and metabolic disorders orientated 
(e.g. insulin resistance) cut-offs for metabolic risk assessment of obese people. For the first 
time, the cut-offs reported here allow a risk assessment of obesity that is comparable for 
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different age groups. It also becomes apparent that the health problem of "being overweight" is 
greater than previously assumed based on statistical normative data. 
 
ZUSAMMENFASSUNG   
112 
 
ZUSAMMENFASSUNG 
Übergewicht und Adipositas werden bei Kindern, Jugendlichen und Erwachsenen ausschließ-
lich anhand des Body Mass Index (BMI) definiert. Die Grenzwerte des BMI sind bei 
Erwachsenen zum Mortalitätsrisiko assoziiert. Hingegen beruhen die Grenzwerte bei Kindern 
und Jugendlichen auf statistisch normativen Analysen und nicht direkt auf gesundheitlichen 
Folgen.  
Übergewicht und Adipositas sind durch eine hohe Fettmasse (FM) gekennzeichnet, die 
wiederum mit kardio-metabolischen Erkrankungen einhergeht. Diese Beziehung wird durch 
den BMI nicht präzise abgebildet. Der BMI kann weder zwischen FM und fettfreier Masse 
(FFM) unterscheiden noch erlaubt er eine detaillierte Beschreibung der Körperfettverteilung. 
Auch der Taillenumfang (TU) ermöglicht keine Aussage zum Verhältnis von viszeralem und 
subkutanem Fettgewebe (VAT, SAT). Letztendlich bestehen zwischen den verschiedenen 
Altersgruppen Unterschiede in der Beziehung zwischen BMI und der Morbidität.  
In dieser Arbeit werden die Beziehungen zwischen anthropometrischen Parametern, 
detaillierter Körperzusammensetzung und kardio-metabolischen Risiken bei Kindern, 
Jugendlichen und Erwachsenen untersucht und systematisch miteinander verglichen. Die 
Ergebnisse zeigen den begrenzten Wert anthropometrischer Parameter in Bezug auf die 
Erfassung von regionalen Fettdepots und kardio-metabolischen Risiken. 
In dieser Arbeit wurde untersucht, ob (i) sich die Zusammenhänge zwischen regionalen 
Fettdepots und kardio-metabolischen Risiken bei normal- und übergewichtigen Kindern, 
Jugendlichen und Erwachsenen unterscheiden, (ii) normative Grenzwerte von BMI und TU, 
verglichen zu anhand der direkten Messung individueller Fettdepots und metabolisch 
definierten Grenzwerten, für die gesundheitliche Bewertung geeignet sind und (iii) FM pro 
Fettgewebe (FG) zur Beurteilung des metabolischen Risikos einen additiven Nutzen hat. 
Die wesentlichen Ergebnisse dieser Arbeit sind: 
(i) Die Zusammenhänge zwischen regionalen Fettdepots und kardio-metabolischen Risiken 
wurden erst nach der Pubertät evident. Die Insulinresistenz war am stärksten mit VAT 
korreliert. Unabhängig vom BMI, war die Insulinresistenz mit VAT ausschließlich im späteren 
Erwachsenenalter assoziiert. 
(ii) Verglichen zum metabolisch definierten Grenzwert sind normative Grenzwerte für die 
Bestimmung der Insulinresistenz bei Kindern, Jugendlichen und Erwachsenen nicht 
angemessen. 
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(iii) FM und FG korrelierten stark. Es bestanden jedoch erhebliche inter-individuelle 
Unterschiede in der FM pro FG. Unabhängig von FM oder FG hat der Fettanteil pro Fettgewebe 
zur metabolischen Risikobewertung beigetragen. 
Diese Ergebnisse belegen die Notwendigkeit von zukünftig differenzierten und an möglichen 
Stoffwechselstörung (wie der Insulinresistenz) orientierten Grenzwerten für die Beurteilung des 
gesundheitlichen Risikos übergewichtiger Menschen. Die hier mitgeteilten Grenzwerte 
erlauben erstmalig eine für die verschiedenen Altersgruppen vergleichbare Risikoeinschätzung 
von Übergewicht. Es wird auch offensichtlich, dass das gesundheitliche Problem 
"Übergewicht" größer ist, als es bisher anhand von statistisch-normativen Daten angenommen 
wurde. 
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